WO2024050080A2 - Methods of biomanufacturing and purifying retinoids - Google Patents
Methods of biomanufacturing and purifying retinoids Download PDFInfo
- Publication number
- WO2024050080A2 WO2024050080A2 PCT/US2023/031838 US2023031838W WO2024050080A2 WO 2024050080 A2 WO2024050080 A2 WO 2024050080A2 US 2023031838 W US2023031838 W US 2023031838W WO 2024050080 A2 WO2024050080 A2 WO 2024050080A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- retinoid
- retinol
- composition
- solvent
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 146
- 238000013406 biomanufacturing process Methods 0.000 title description 4
- 150000004492 retinoid derivatives Chemical class 0.000 claims abstract description 141
- 239000000203 mixture Substances 0.000 claims abstract description 97
- 238000000638 solvent extraction Methods 0.000 claims abstract description 93
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 58
- 239000010779 crude oil Substances 0.000 claims abstract description 53
- 238000000855 fermentation Methods 0.000 claims abstract description 47
- 230000004151 fermentation Effects 0.000 claims abstract description 47
- 239000007788 liquid Substances 0.000 claims abstract description 42
- 238000000926 separation method Methods 0.000 claims abstract description 22
- 238000002156 mixing Methods 0.000 claims abstract description 13
- 239000007787 solid Substances 0.000 claims abstract description 7
- 239000002699 waste material Substances 0.000 claims abstract description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 455
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 256
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 232
- 229960003471 retinol Drugs 0.000 claims description 211
- 239000011607 retinol Substances 0.000 claims description 211
- 235000020944 retinol Nutrition 0.000 claims description 210
- 239000002904 solvent Substances 0.000 claims description 68
- 239000003921 oil Substances 0.000 claims description 50
- 235000019198 oils Nutrition 0.000 claims description 49
- 238000001704 evaporation Methods 0.000 claims description 44
- 239000012539 chromatography resin Substances 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 230000008020 evaporation Effects 0.000 claims description 33
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 32
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 30
- 238000004191 hydrophobic interaction chromatography Methods 0.000 claims description 27
- 238000000935 solvent evaporation Methods 0.000 claims description 22
- -1 jojoba oil Substances 0.000 claims description 21
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 20
- 239000002537 cosmetic Substances 0.000 claims description 17
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- 238000005119 centrifugation Methods 0.000 claims description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 14
- 235000019486 Sunflower oil Nutrition 0.000 claims description 14
- 239000002600 sunflower oil Substances 0.000 claims description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 10
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 10
- 239000008158 vegetable oil Substances 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 9
- 239000002480 mineral oil Substances 0.000 claims description 9
- 239000008194 pharmaceutical composition Substances 0.000 claims description 9
- 239000010408 film Substances 0.000 claims description 8
- 235000010446 mineral oil Nutrition 0.000 claims description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 8
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 8
- 238000004366 reverse phase liquid chromatography Methods 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 7
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims description 6
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 6
- 239000003937 drug carrier Substances 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 235000014121 butter Nutrition 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 4
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 4
- 230000006696 biosynthetic metabolic pathway Effects 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 4
- 239000001963 growth medium Substances 0.000 claims description 4
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 3
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 3
- 235000019482 Palm oil Nutrition 0.000 claims description 3
- 235000019483 Peanut oil Nutrition 0.000 claims description 3
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 3
- 235000019774 Rice Bran oil Nutrition 0.000 claims description 3
- 235000019485 Safflower oil Nutrition 0.000 claims description 3
- 235000019498 Walnut oil Nutrition 0.000 claims description 3
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 3
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 3
- 229940036350 bisabolol Drugs 0.000 claims description 3
- 235000019519 canola oil Nutrition 0.000 claims description 3
- 239000000828 canola oil Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 239000004359 castor oil Substances 0.000 claims description 3
- 235000019438 castor oil Nutrition 0.000 claims description 3
- 235000019868 cocoa butter Nutrition 0.000 claims description 3
- 229940110456 cocoa butter Drugs 0.000 claims description 3
- 235000019864 coconut oil Nutrition 0.000 claims description 3
- 239000003240 coconut oil Substances 0.000 claims description 3
- 235000012716 cod liver oil Nutrition 0.000 claims description 3
- 239000003026 cod liver oil Substances 0.000 claims description 3
- 235000012343 cottonseed oil Nutrition 0.000 claims description 3
- 239000002385 cottonseed oil Substances 0.000 claims description 3
- 238000009295 crossflow filtration Methods 0.000 claims description 3
- 229940075894 denatured ethanol Drugs 0.000 claims description 3
- 239000011552 falling film Substances 0.000 claims description 3
- 238000004508 fractional distillation Methods 0.000 claims description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 3
- 239000008169 grapeseed oil Substances 0.000 claims description 3
- 238000001990 intravenous administration Methods 0.000 claims description 3
- 229940119170 jojoba wax Drugs 0.000 claims description 3
- 239000010485 kapok seed oil Substances 0.000 claims description 3
- 239000000944 linseed oil Substances 0.000 claims description 3
- 235000021388 linseed oil Nutrition 0.000 claims description 3
- 239000004006 olive oil Substances 0.000 claims description 3
- 235000008390 olive oil Nutrition 0.000 claims description 3
- 239000003346 palm kernel oil Substances 0.000 claims description 3
- 235000019865 palm kernel oil Nutrition 0.000 claims description 3
- 239000002540 palm oil Substances 0.000 claims description 3
- 239000000312 peanut oil Substances 0.000 claims description 3
- 239000001738 pogostemon cablin oil Substances 0.000 claims description 3
- 229920013639 polyalphaolefin Polymers 0.000 claims description 3
- 239000010491 poppyseed oil Substances 0.000 claims description 3
- 239000008165 rice bran oil Substances 0.000 claims description 3
- 235000005713 safflower oil Nutrition 0.000 claims description 3
- 239000003813 safflower oil Substances 0.000 claims description 3
- 238000004062 sedimentation Methods 0.000 claims description 3
- 235000012424 soybean oil Nutrition 0.000 claims description 3
- 239000003549 soybean oil Substances 0.000 claims description 3
- 239000010409 thin film Substances 0.000 claims description 3
- 238000011200 topical administration Methods 0.000 claims description 3
- 239000002383 tung oil Substances 0.000 claims description 3
- 239000008170 walnut oil Substances 0.000 claims description 3
- 239000010497 wheat germ oil Substances 0.000 claims description 3
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 abstract description 33
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 abstract description 33
- 229930002886 farnesol Natural products 0.000 abstract description 33
- 229940043259 farnesol Drugs 0.000 abstract description 33
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 abstract description 33
- 230000008569 process Effects 0.000 description 35
- 239000000047 product Substances 0.000 description 29
- 238000000605 extraction Methods 0.000 description 23
- 239000011347 resin Substances 0.000 description 22
- 229920005989 resin Polymers 0.000 description 22
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 21
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 21
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 21
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 21
- 238000002474 experimental method Methods 0.000 description 20
- 239000012071 phase Substances 0.000 description 19
- 238000010828 elution Methods 0.000 description 18
- 235000019169 all-trans-retinol Nutrition 0.000 description 17
- 239000011717 all-trans-retinol Substances 0.000 description 17
- 229940100609 all-trans-retinol Drugs 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000003463 adsorbent Substances 0.000 description 11
- 230000015556 catabolic process Effects 0.000 description 9
- 238000006731 degradation reaction Methods 0.000 description 9
- 239000003963 antioxidant agent Substances 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 8
- 230000002209 hydrophobic effect Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000012535 impurity Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 7
- 238000011068 loading method Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 229960001295 tocopherol Drugs 0.000 description 5
- 235000010384 tocopherol Nutrition 0.000 description 5
- 239000011732 tocopherol Substances 0.000 description 5
- 229930003799 tocopherol Natural products 0.000 description 5
- AFABGHUZZDYHJO-UHFFFAOYSA-N 2-Methylpentane Chemical compound CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 238000011021 bench scale process Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000012088 reference solution Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 238000010924 continuous production Methods 0.000 description 3
- 239000003398 denaturant Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012527 feed solution Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 238000013341 scale-up Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- FPIPGXGPPPQFEQ-HWCYFHEPSA-N 13-cis-retinol Chemical compound OC/C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-HWCYFHEPSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920002614 Polyether block amide Polymers 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000010011 Vitamin A Deficiency Diseases 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- FPIPGXGPPPQFEQ-DPZDGVIMSA-N dihydroretinol Natural products CC(=CCO)C=CC=C(C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-DPZDGVIMSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 238000002481 ethanol extraction Methods 0.000 description 2
- 235000003869 genetically modified organism Nutrition 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000007951 isotonicity adjuster Substances 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 230000002207 retinal effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- FPIPGXGPPPQFEQ-HPNHMNAASA-N 11-cis-retinol Natural products OCC=C(C)C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-HPNHMNAASA-N 0.000 description 1
- FPIPGXGPPPQFEQ-MKOSUFFBSA-N 9-cis-retinol Chemical compound OC\C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-MKOSUFFBSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000208818 Helianthus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000003822 cell turnover Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000011210 chromatographic step Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000010963 scalable process Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000008833 sun damage Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 208000005494 xerophthalmia Diseases 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
- C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Definitions
- This invention relates to methods of biomanufacturing and purifying retinoids.
- Retinoids in particular all-trans retinol
- Retinoids has been widely used in the cosmetic industry for its anti-aging properties and as a supplement to treat vitamin A deficiency.
- Commercially available retinol has been chemically synthesized.
- One known limitation of chemically synthesizing retinol is the cost and yield. Fermentation can be a cheaper alternative to chemical synthesis, and provides the opportunity to produce and purify retinol at large scale.
- a retinoid that include: providing a fermentation broth comprising the retinoid and an overlay ; performing a liquid-solid and a liquid-liquid separation on the fermentation broth to produce a crude oil and a waste heavy phase; mixing the crude oil with a solvent extraction system to extract the retinoid from the crude oil; and stripping the solvent extraction system from the extracted retinoid to thereby isolate the retinoid.
- the solvent extraction system comprises ethanol, isopropyl alcohol (IP A), acetone, or propanediol, or a combination thereof. In some embodiments, the solvent extraction system comprises about 70 wt% to about 99.95 wt% ethanol.
- the solvent extraction system comprises acetic acid, acetonitrile, methanol, n-propanol, methyl acetate, ethyl acetate, n-hexane, cyclohexane, or n- heptane.
- the solvent extraction system includes ethanol, wherein the ethanol is free of additives. In some embodiments, the ethanol free of additives is a denatured ethanol. In some embodiments, the solvent extraction system includes ethanol and isopropyl alcohol. In some embodiments, the solvent extraction system includes between about 90% and about 99% (e.g., about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, or about 99%) ethanol and between about 1% and about 10% (e.g., about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, or about 10%) isopropyl alcohol. In some embodiments, the solvent extraction system includes about 95% ethanol and about 5% isopropyl alcohol.
- the solvent extraction system includes ethanol and n-heptane.
- the solvent extraction system includes between about 90% and about 99% (e.g., about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, or about 99%) ethanol and between about 1% and about 10% (e.g., about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, or about 10%) n-heptane.
- the solvent extraction system includes about 95% ethanol and about 5% n-heptane.
- the solvent extraction system includes ethanol, methanol, ethyl acetate, and 4-methylpentan-2-one. In some embodiments, the solvent extraction system includes between about 90% and about 100% (e.g., about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, about 99%, or about 100%) ethanol, between about 3% and about 5% (about 3%, about 3.5%, about 4%, about 4.5%, about 4.6%, about 4.8%, about 4.9%, or about 5%) methanol, between about 1% and about 5% (e.g., about 1 %, about 1 .5%, about 2%, about 2.5%, about 3%, about 3.55, about 4%, about 4.5%, about 4.6%, about 4.8%, about 4.9%, or about 5%) ethyl acetate, between about 1% and about 5% (e.g., about 1%, about 1.5%, about 2%, about 2.5%, between about 1%
- the solvent extraction system includes between about 90% and about 99% ethanol, between about 3% and about 4.5% methanol, between about 1% and about 4% ethyl acetate, and between about 1% and about 4% 4-methylpentan-2-one.
- the solvent extraction system includes between about 90% ethanol, about 3% methanol, about 1%, ethyl acetate, about 1% 4-methylpentan-2-one.
- the solvent extraction system comprises methylene chloride, ethyl ether, chloroform, or carbon tetrachloride.
- the water content in the solvent extraction system is between about 0% to about 60%. In some embodiments of any of the methods described herein, the mass ratio of the solvent extraction system to crude oil ranges from about 10: 1 to about 100:1.
- the mass ratio of the solvent extraction system to crude oil ranges from about 1 : 1 to about 5: 1.
- the overlay comprises a mineral oil and/or a vegetable oil.
- the overlay comprises mineral oil, and the mineral oil is Durasyn® 164 polyalphaolefin or Drakeol® 10.
- the overlay comprises vegetable oil
- the vegetable oil is butter, bisabolol oil, canola oil, castor oil, cocoa butter, coconut oil, cod liver oil, com oil, cottonseed oil, grape seed oil, jojoba oil, kapok seed oil, linseed oil, olive oil, palm kernel oil, palm oil, patchouli oil, peanut oil, poppyseed oil, rapeseed oil, rice bran oil, safflower oil, soybean oil, sunflower oil, tung oil, walnut oil, or wheat germ oil, or a mixture thereof.
- the liquid-liquid separation comprises centrifugation, filtration with a functionalized membrane, tangential flow filtration, and/or sedimentation.
- the stripping the solvent extraction system comprises decanting for about 30 minutes to about 24 hours. In some embodiments, stripping the solvent extraction system comprises evaporation or fractional distillation. In some embodiments, the solvent evaporation is performed in a single step. In other embodiments, the solvent evaporation is performed in multiple steps (e.g., two, three, four, five, or six steps).
- the solvent evaporation includes a rising-film evaporator, a falling-film evaporator, a wiped film evaporation, an agitated thin film, or a plate.
- the solvent evaporation is performed in two-steps. In some embodiments, the solvent evaporation is performed in two-steps with recirculation or without recirculation.
- stripping the solvent extraction system comprises evaporating the solvent at a temperature of less than about 50 °C. In some embodiments, stripping the solvent extraction system comprises evaporating solvent at a temperature of about 50 °C to about 200 °C.
- the method further includes feeding the isolated retinoid into a chromatography system comprising a hydrophobic interaction chromatography resin or a reverse-phase chromatography resin.
- the hydrophobic interaction chromatography resin is a hydrophobic interaction chromatography resin with a particle size of about 63 pm to about 150 pm.
- the method further includes filtering the isolated retinoid prior to feeding the isolated retinoid into the chromatography system.
- the method further includes evaporating solvent at a temperature less than 50 °C.
- the method further includes adding a high oleic oil thereby producing a cosmetic composition.
- the high oleic oil is a high oleic organic sunflower oil.
- the retinoid is retinol.
- a composition comprising the retinoid and farnesol that include: providing a composition comprising the retinoid and famesol; feeding the composition into a chromatography system; and collecting the retinoid, thereby isolating the retinoid.
- the chromatography system comprises a hydrophobic interaction chromatography resin or a reverse-phase chromatography resin.
- the hydrophobic interaction chromatography resin is a hydrophobic interaction chromatography resin with a particle size of about 63 pm to about 150 pm.
- the chromatography resin is PuroliteTM PCG600, Mitsubishi DiaionTM HP20SS, PuroliteTM PCG1200.
- the method further includes filtering the isolated retinoid prior to feeding the composition into the chromatography system. In some embodiments, the method further includes evaporating solvent at a temperature less than 50 °C. In some embodiments, the method further includes adding a high oleic oil thereby produce a cosmetic composition. In some embodiments, the high oleic oil is a high oleic organic sunflower oil.
- compositions including the retinoid produced by any of the methods described herein.
- the composition is a liquid or a semiliquid.
- the composition is formulated for oral administration, topical administration, or intravenous administration.
- the composition is formulated as a sublingual drop, a gel capsule, or a spray.
- compositions and pharmaceutical compositions including the retinoid produced by any of the methods described herein include a pharmaceutically acceptable carrier and/or excipient.
- pharmaceutically acceptable carrier and/or excipient is an adjuvant.
- compositions including a retinoid wherein the retinoid is produced by a method including: a) culturing a population of host cells that are genetically modified to express one or more enzymes of a retinoid biosynthetic pathway in a culture medium and under conditions suitable for the population of host cells to produce the retinoid, thereby producing a fermentation composition; and b) recovering the retinoid from the fermentation composition, wherein the retinoid is present in the composition with a purity of between 40% w/w and 99.9% w/w (e.g., between 40% w/w and 90% w/w, between 40% w/w and 80% w/w, between 40% w/w and 70% w/w, between 50% w/w and 99.9% w/w, between 50% w/w and 90% w/w, between 50% w/w and 80% w/w, between 50% w/w and 70% w/w, between 60% w/w and 99.
- solvent extraction system refers to one or more component(s) that are used in a process by which a composition comprising a retinoid (e.g., retinol) (e.g., a fermentation broth comprising a retinoid (e.g., a fermentation broth comprising retinol), a liquid compnsing a retinoid (e.g.
- a retinoid e.g., retinol
- a fermentation broth comprising a retinoid e.g., a fermentation broth comprising retinol
- a liquid compnsing a retinoid e.g.
- a liquid comprising retinol), or a crude oil containing a retinoid is separated, based on physiochemical properties (e.g., solubility or distribution coefficient), into two or more (e.g., 2, 3, or 4, or more) different immiscible phases.
- solvent extraction removes retinol from oil (overlay) to the solvent phase.
- a solvent extraction system may include a single solvent, or a mixture of solvents.
- Non-limiting examples of solvents include: ethanol, isopropyl alcohol (IP A), acetone, or propanediol, acetic acid, acetonitrile, methanol, n-propanol, methyl acetate, ethyl acetate, n-hexane, cyclohexane, n-heptane, methylene chloride, ethyl ether, chloroform, carbon tetrachloride, and isohexane.
- the selection of a particular solvent can depend, for example, on its distribution coefficient, selectivity, (in)solubility, recoverability, viscosity, vapor pressure, thermostability, toxicity, allergenic properties, availability, and/or cost.
- solvent evaporation refers to the step(s) in which the solvent is removed from a retinoid (e.g., retinol) by evaporation.
- Solvent evaporation can be performed in a single step or in multiple steps in series.
- Non-limiting examples solvent evaporation include use of a tank or tubular, rising-film evaporator (RFE), falling-film evaporator, wiped film evaporation (WFE), agitated thin film, or a plate.
- RFE rising-film evaporator
- WFE wiped film evaporation
- solvent evaporation requires the presence of stream recirculation.
- solvent evaporation does not require stream recirculation.
- the solvent evaporation occurs in batch mode.
- the solvent evaporation occurs in fed-batch mode.
- the solvent evaporation is continuous.
- clarified fermentation broth means a fermentation broth obtained from a cell culture that is substantially free of cells (e.g., whole bacteria, or whole yeast cells).
- substantially free refers to a composition (e.g., a purified product) that is at least about 80% free (e.g., at least about 85%, 90%, 95%, 96%, 97%, 98%, or 99% free) of a specified substance (e.g., famesol).
- a composition e.g., a purified product
- a specified substance e.g., famesol
- liquid-liquid separation refers to any liquid-liquid separation technique that partially or fully separates one or more liquid phases that are immiscible (e.g., one or more oils (e.g., 1, 2, 3 oils) and/or combinations of one or more oils and one or more solvents (e.g., two solvents) from a waste heavy phase.
- a liquid-liquid separation can demulsify an emulsion (e.g., an emulsion and aqueous phase, an oil and emulsion).
- Non-limiting examples of liquid-liquid separation include use of a decanter, a solvent, or a combination thereof.
- purifying means performing at least one step to isolate a retinoid (e.g., retinol) from one or more other impurities (e.g., bulk impurities, whole cell debris, and/or famesol) and/or components present in a liquid that comprises a retinoid (e.g., retinol) (e.g., a clarified fermentation broth comprising a retinoid (e.g., a clarified fermentation broth comprising retinol), or a crude oil), or one or more other components (e.g., DNA, RNA, other proteins, endotoxins, viruses etc.) present in or secreted from cells within a fermentation broth.
- a retinoid e.g., retinol
- impurities e.g., bulk impurities, whole cell debris, and/or famesol
- components present in a liquid that comprises a retinoid (e.g., retinol) e.g., a
- filter(ing) refers to the removal of at least some (e.g., at least 80%, 90%, 95%, 96%, 97%, 98%, or 99%) undesired biological contaminants (e.g., a cell), and/or solvents, from a liquid that comprises a retinoid (e.g., retinol) (e.g., a clarified fermentation broth comprising a retinoid (e.g., retinol), or a crude oil).
- a retinoid e.g., retinol
- a clarified fermentation broth comprising a retinoid (e.g., retinol)
- a crude oil e.g., a crude oil
- sample is a term of art and refers to a liquid that exits a chromatography column of a chromatography system that includes a detectable amount of a retinoid (e.g., retinol).
- a retinoid e.g., retinol
- continuous process means a process that continuously feeds a liquid (e.g., a fermentation broth, a clarified fermentation broth, crude oil, a liquid comprising a retinoid (e g., retinol), and/or a composition comprising a retinoid (e g., retinol)) through at least a part of a process.
- a liquid e.g., a fermentation broth, a clarified fermentation broth, crude oil, a liquid comprising a retinoid (e g., retinol), and/or a composition comprising a retinoid (e g., retinol)
- a liquid comprising a retinoid e.g., retinol
- a retinoid e.g., retinol
- a fermentation broth e.g., a clarified fermentation broth, crude oil
- a liquid comprising a retinoid e.g., retinol
- a composition comprising a retinoid e.g., retinol
- closed process is a term of art that means a process that is performed such that components of the process (e.g., liquid-liquid separation, solvent extraction system, chromatography system) that come into contact with a retinoid (e.g., retinol) are not intentionally exposed to contaminating agents for a significant period of time (e.g., not intentionally air-exposed for a significant period of time).
- a retinoid e.g., retinol
- chromatography system means a system that includes one or more interconnected or switching chromatography columns and/or chromatographic membranes.
- a non-limiting example of a chromatography system is simulated moving bed chromatography. Additional examples of chromatography systems are described herein and are known in the art.
- FIG. 1 is an exemplary process flow diagram for extraction of retinol.
- FIG. 2 shows the chemical structure of retinol.
- FIG. 3 shows the chemical structure of famesol.
- FIG. 4A is a chromatogram of gradient elution of a reference solution (1 wt% retinol, 1 wt% farnesol and 0.01 wt% (butylated hydroxytulene (BHT) in 90/10 ethanol/water solution) using a column packed with Diaion HP20SS (Mitsubishi Chemical). Retinol and farnesol were identified at wavelengths 325 nm and 200 nm, respectively.
- FIG. 4B is a chromatogram of gradient elution of a reference solution (1 wt% retinol, 1 wt% famesol and 0.01 wt% (BHT) in 90/10 ethanol/water solution) using a column packed with Purolite PCG600. Retinol and farnesol were identified at wavelengths 325 nm and 200 nm, respectively.
- FIG. 4C is a chromatogram of gradient elution of a reference solution (1 wt% retinol, 1 wt% famesol and 0.01 wt% (BHT) in 90/10 ethanol/water solution) using a column packed with Purolite PCG950. Retinol and farnesol were identified at wavelengths 325 nm and 200 nm, respectively.
- FIG. 5 is an exemplary process flow diagram for isolation of retinol that includes steps of filtration, product purification, solvent evaporation, and blending after solvent extraction.
- FIG. 6 is an exemplary process flow diagram showing an exemplary process for retinol extraction. Processes are shown in solid lines (e g , fermentation, liquid-solid centrifugation, liquid-liquid centrifugation, solvent extraction, evaporation, blend). Streams (e.g., light phase, heavy phase) are shown in dashed lines.
- solid lines e.g , fermentation, liquid-solid centrifugation, liquid-liquid centrifugation, solvent extraction, evaporation, blend.
- Streams e.g., light phase, heavy phase
- FIG. 7 is a schematic diagram showing one example of solvent extraction of retinol with two feed solutions: (A) Oil feed containing retinol and (B) solvent feed are the inputs and the outputs are (C) the oil layer and (D) the solvent extract.
- the solvent outlet is the main product, and contains most of the retinol at the end of the process.
- FIG. 8A is a graph showing retinol yield (by loss) against ethanol: oil extraction ratios (1, 3, 4.5, and 5) within a glovebox and outside of a glovebox. Moisture and oxygen are removed from the inert atmosphere of a glovebox, which minimizes the amount of moisture that is taken up by the solvent (ethanol). Conditions outside of a glovebox mimic experimental conditions suitable for scale-up manufacturing.
- FIG. 8B is a graph showing butylated hydroxytulene (BHT) yield (by loss) against ethanol: oil extraction ratios (1, 3, 4.5, and 5) within a glovebox and outside of a glovebox.
- FIG. 9 is a graph showing BHT: retinol ratio in solvent phase against ethanol: crude oil extraction ratios (1, 3, 4.5, and 5) within a glovebox and outside of a glovebox.
- FIG. 10 is a graph showing famesol/retinol in product [wt%] and retinol yield [%] following twenty two consecutive chromatography runs.
- the present disclosure is directed, in part, to methods of isolating a retinoid (e.g., retinol), including, for example, from a fermentation broth or other liquid comprising a retinoid (e.g., retinol) or both a retinoid (e.g., retinol) and famesol.
- a retinoid e.g., retinol
- famesol e.g., famesol
- the methods can include, e.g., providing a fermentation broth comprising a retinoid (e.g., retinol); performing a liquidliquid separation on the fermentation broth to produce a crude oil and a waste heavy phase; mixing the crude oil with a solvent extraction system to extract the retinoid (e.g., retinol) from the crude oil; and stripping the solvent extraction system from the extracted retinoid (e.g., retinol) to thereby isolate the retinoid (e.g., retinol).
- a solvent extraction system to extract the retinoid (e.g., retinol) from the crude oil
- stripping the solvent extraction system from the extracted retinoid e.g., retinol
- a retinoid e.g., retinol
- the methods can include, for example, providing a composition including a retinoid (e.g., retinol) and farnesol; feeding the composition into a chromatography system; and collecting the retinoid (e.g., retinol), thereby isolating the retinoid (e.g., retinol) from the farnesol.
- Retinol or vitamin A alcohol is the main circulating form of vitamin A found in plasma. Retinol has been shown to be involved in cellular differentiation and proliferation. Retinol or all-tra s -retinol is a 20-carbon molecule with a cyclohexenyl ring, a side chain with four double bonds (in trans configuration), and an alcohol end group (FIG. 2). Retinol has a molecular weight of 286.45 and has the following chemical structure: Retinol is commercially available as a crystalline material with a melting point in the 62 °C to 64 °C range. Retinol is known to degrade with exposure to UV, oxygen, and temperature.
- Retinol Exposure to light is preferentially minimized during biomanufacturing, purification and experimentation.
- Retinol has been used extensively in a variety of antiaging cosmetic products as well as for treatment of skins disorders, such as acne, psoriasis, age spots, discoloration, and melasma.
- Retinol is used to reduce the effects of stress in skin and sun damage. It can also enhance cell turnover, promote collagen production, facilitate wound healing, and reduce wrinkles and fine lines. Since retinol is only naturally found in animal- derived products, such as milk, cheese, butter, and liver, it is also used as a dietary supplement for vitamin A deficiency (e.g., night blindness and xerophthalmia). Retinol is converted into retinal and retinoic acid.
- vitamin A deficiency e.g., night blindness and xerophthalmia
- the methods can generally include the steps of providing a fermentation broth including a retinoid (e.g., retinol) and an overlay; performing a liquid-liquid separation on the fermentation broth to produce a crude oil and a waste heavy phase; mixing the crude oil with a solvent extraction system to extract retinoid (e.g., retinol) from the crude oil; and stripping the solvent extraction system from the extracted retinoid (e.g., retinol) to thereby isolate the retinoid (e.g., retinol).
- retinoid e.g., retinol
- a fermentation broth that includes a retinoid can be generated using any fermentation method employing microorganisms capable of producing a retinoid (e.g., retinol).
- a retinoid e.g., retinol
- Methods of genetically modifying microorganisms to produce proteins of interest are known in the art and can be used to modify or cause the expression of enzymes, such as those involved in the production of a retinoid (e.g., retinol), such that large quantities of a retinoid (e.g., retinol) are produced by the microorganisms.
- antioxidants e.g., BHT
- BHT antioxidants
- Processes described herein can include adding an overlay to the fermentation broth.
- An overlay can, for example, create anaerobic conditions such that a retinoid (e.g., retinol) is not degraded during the isolation process.
- the overlay can include, e.g., a mineral oil and/or a vegetable oil.
- Exemplary mineral oils include, e.g., Durasyn® 164 polyalphaolefin or Drakeol® 10 white mineral oil.
- Exemplary vegetable oils include butter, bisabolol oil, canola oil, castor oil, cocoa butter, coconut oil, cod liver oil, com oil, cottonseed oil, grape seed oil, jojoba oil, kapok seed oil, linseed oil, olive oil, palm kernel oil, palm oil, patchouli oil, peanut oil, poppyseed oil, rapeseed oil, rice bran oil, safflower oil, soybean oil, sunflower oil, tung oil, walnut oil, or wheat germ oil, or a mixture of at least two of any of such oils.
- liquid-solid separation can be performed using methods known to those of skill in the art.
- liquid-liquid separation can include centrifugation, filtration with a functionalized membrane (e.g., hydrophobic membranes (e.g., polymeric hydrophobic membranes (e.g., PTFE (polytetrafluoroethylene), PDMS (poly dimethyl siloxane), POMS (poly octy lmethyl siloxane) or PEBA (polyether block amide))) and hydrophilic membranes (e.g., Silica-based membranes, zeolite membranes), tangential flow filtration, and/or sedimentation.
- a functionalized membrane e.g., hydrophobic membranes (e.g., polymeric hydrophobic membranes (e.g., PTFE (polytetrafluoroethylene), PDMS (poly dimethyl siloxane), POMS (poly octy lmethyl siloxane) or PEBA (poly
- Liquid-solid separation can include a step of decanting to separate a liquid from a suspension of insoluble particles and biomass debris (e.g., microorganisms, bacteria, pollutants).
- decanting can be performed for about 30 minutes to about 24 hours (e.g., about 30 minutes to about 3 hours, about 1 hour to about 6 hours, about 1 hour to about 3 hours, or about 1 hour to about 2 hours).
- Mixing the crude oil with a solvent extraction system can include, for example, mixing the crude oil with a solvent extraction system for about 5 minutes to about 3 hours (e.g., about 5 minutes to about 45 minutes, about 15 minutes to about 1 hour, or about 15 minutes to about 30 minutes). Tn some instances, mixing is carried out using rotary agitation. For example, mixing can be performed at a rotary agitation speed of about 300 rotations per minute (RPM) to about 1000 RPM (e.g., about 300 RPM to about 900 RPM, about 300 RPM to about 500 RPM, or about 500 RPM to about 1000 RPM).
- RPM rotations per minute
- a solvent extraction system is used to selectively extract a retinoid (e g., retinol) from the oil phase of a crude oil containing the retinoid (e.g., retinol).
- a retinoid e.g., retinol
- Skilled practitioners will appreciate that a number of different solvent extraction systems can be selected, depending on the desired outcome and the conditions under which the extraction will be performed.
- the solvent extraction system can include one or more of acetic acid, acetonitrile, methanol, ethanol, acetone, isopropanol, n-propanol, methyl acetate, ethyl acetate, methylene chloride, ethyl ether, chloroform, carbon tetrachloride, n-hexane, isohexane, denatured ethanol, cyclohexane, n-heptane, and mixtures of any two or more of such compositions.
- the solvent extraction system does not include one or more solvents, e.g., in some instances the solvent extraction system may specifically not include methylene chloride, ethyl ether, chloroform, carbon tetrachloride, or a combination thereof.
- a particularly useful solvent extraction system for use in the presently described methods include ethanol (EtOH), isopropyl alcohol (IP A), acetone, propanediol, or any combination thereof.
- solvent extraction systems described herein can include a water content in the solvent/water mixture of about 0% to about 60% (e.g., about 1% to about 25, about 1% to about 45%, about 1% to about 60%, about 5% to about 45%, about 5% to about 30%, about 10% to about 25%, about 25% to about 60%, or about 30% to about 50%).
- the solvent extraction system includes ethanol at about 70 wt% to about 99.95 wt% (e.g., about 70 vt% to about 95 wt%, about 80 wt% to about 99% wt%, about 80 wt% to about 95 wt%, about 90 wt% to about 99% wt%, about 90 wt% to about 95 wt%, or about 90 wt% to about 92 wt%).
- ethanol at about 70 wt% to about 99.95 wt% (e.g., about 70 vt% to about 95 wt%, about 80 wt% to about 99% wt%, about 80 wt% to about 95 wt%, about 90 wt% to about 99% wt%, about 90 wt% to about 95 wt%, or about 90 wt% to about 92 wt%).
- the mass ratio of any of the solvent extraction systems described herein to crude oil can range from about 10: 1 to about 100: 1 (e.g., about 10: 1 to about 80:1, about 10: 1 to about 50: 1, about 10: 1 to about 20:1, about 20:1 to about 100: 1, about 20:1 to about 50: 1, about 50: 1 to about 100: 1, about 70: 1 to about 100:1, or about 80: 1 to about 100: 1).
- the mass ratio of the solvent extraction system to crude oil ranges from about 1 : 1 to about 5:1 (e g., about 1 : 1 to about 4: 1 , about 1 : 1 to about 3: 1 , about 1: 1 to about 2:1, , about 2: 1 to about 4: 1, about 3: 1 to about 4: 1, e.g., about 1: 1, about 2: 1, about 3: 1, about 4: 1, or about 5: 1).
- the solvent extraction system may be stripped. Stripping of the solvent extraction system is useful to separate more than two types of components from each other in an otherwise homogenous mixture. Stripping the solvent extraction system can include evaporation or fractional distillation.
- stripping the solvent extraction system can include evaporating solvent at a temperature of about 50 °C to about 200 °C (e.g., about 50 °C to about 180°C, about 50 °C to about 120°C, about 50 °C to about 100 °C, about 75 °C to about 200 °C, about 75 °C to about 100 °C, about 100 °C to about 200 °C, about 100 °C to about 180 °C, about 100 °C to about 150°C, about 100 °C to about 120 °C, about 150°C to about 200 °C, or about 150 °C to about 180 °C).
- about 50 °C to about 200 °C e.g., about 50 °C to about 180°C, about 50 °C to about 120°C, about 50 °C to about 100 °C, about 75 °C to about 200 °C, about 75 °C to about 100 °C, about 100 °C to about 200 °C, about
- stripping the solvent extraction system can include, e.g., evaporating the solvent at a temperature of less than about 50 °C (e.g., between about 20 °C to about 48 °C, between about 20 °C to about 45 °C, or between about 20 °C to about 30 °C).
- Retinol can optionally be separated from famesol before the solvent system is removed.
- Farnesol has the following chemical structure:
- farnesol is not readily separated from retinol using evaporation without resulting in at least some retinol degradation.
- farnesol and retinol can successfully be separated using a chromatography system.
- a chromatography system comprising a hydrophobic interaction chromatography resin (e.g., any of the hydrophobic interaction chromatography resins described herein) or a reverse-phase chromatography resin (e.g., any of the reversephase chromatography resins)
- a hydrophobic interaction chromatography resin e.g., any of the hydrophobic interaction chromatography resins described herein
- a reverse-phase chromatography resin e.g., any of the reversephase chromatography resins
- Exemplary chromatography resins include PuroliteTM PCG600 (polystyrenic macroporous adsorbent non-functionalized resin), Mitsubishi DiaionTM HP20SS (styrene-DVB porous adsorbent resin), PuroliteTM PCG1200 (polystyrenic macroporous adsorbent non-functionalized resin).
- the liquid comprising the isolated retinoid may be filtered prior to feeding the isolated retinoid (e.g., retinol) into a chromatography system.
- This filtration system removes particulates in the liquid containing the isolated retinoid (e.g., retinol) that could clog or reduce the efficacy of the chromatography resin.
- a hydrophobic interaction chromatography resin can include a particle size of about 50 pm to about 900 pm (e.g., about 50 pm to about 600 pm, about 50 pm to about 500 pm, about 50 pm to about 200 pm, about 50 pm to about 150 pm, about 50 pm to about 100 pm, about 50 pm to about 80 pm, about 60 pm to about 600 pm, about 60 pm to about 500 pm, about 60 pm to about 200 pm, about 60 pm to about 180 pm, about 60 pm to about 120 pm, about 60 pm to about 100 pm, about 60 pm to about 80 pm, about 100 pm to about 600 pm, about 100 pm to about 500 pm, about 100 pm to about 200 pm, about 100 pm to about 200 pm, about 100 pm to about 150 pm, about 200 pm to about 600 pm, about 200 pm to about 500 pm, or about 500 pm to about 600 pm).
- a particle size of about 50 pm to about 900 pm e.g., about 50 pm to about 600 pm, about 50 pm to about 500 pm, about 50 pm to about 200 pm, about 50 pm to about 150 pm, about 50
- the hydrophobic interaction chromatography resins can, for example, have a porosity of about 50 angstrom to about 500 angstrom (e.g., about 50 angstrom to about 200 angstrom, about 50 angstrom to about 100 angstrom, about 75 angstrom to about 250 angstrom about 75 angstrom to about 100 angstrom, about 100 angstrom to about 350 angstrom, about 100 angstrom to about 250 angstrom, about 100 angstrom to about 200 angstrom, or about 100 angstrom to about 150 angstrom).
- methods described herein can further include one or more optional steps of adding one or more components to prepare the retinoid (e g., retinol) for use in various applications.
- an antioxidant can be added to the isolated retinoid (e.g., retinol).
- Such a step can be particularly useful, for example, to make a cosmetic product, as the antioxidant can ameliorate or prevent oxidation of the cosmetic product formulation.
- Non-limiting examples of antioxidants include: butylated hydroxytoluene (BHT), camosic acid, tocobiol® SF ER (a mixture of tocopherol from sunflower oil and vegetable oil), tocobiol® XT (a mixture of tocopherol with green tea extract), tocobiol® SF (a mixture of tocopherol from sunflower oil), tocobiol® ER, tocobiol® (a mixture of tocopherol from vegetable oil or sunflower oil), alpha-tocopherol, tocopherol, D-alpha-tocopherol acetate, and propyl gallate.
- BHT butylated hydroxytoluene
- camosic acid tocobiol® SF ER
- tocobiol® XT a mixture of tocopherol with green tea extract
- tocobiol® SF a mixture of tocopherol from sunflower oil
- tocobiol® ER tocobiol® (a mixture of tocopherol from vegetable oil or sunflower oil
- methods described herein can further include adding various components to the isolated retinoid (e.g., retinol), or vice- versa, to produce various products.
- the isolated retinoid e.g., retinol
- can be added to various other components to produce a cosmetic composition e.g., essential oils, butters, oils.
- a high oleic oil e g., a high oleic sunflower oil
- Exemplary cosmetic compositions include skin creams, lotions, serums, sprays, moisturizers, and the like.
- the isolated retinoid e.g., retinol
- a pharmaceutical composition such as atopical composition or an injectable composition to treat various disorders.
- the isolated retinoid e.g., retinol
- the methods can include, for example, providing a composition including a retinoid and famesol; feeding the composition into a chromatography system (e.g., a chromatography system comprising a hydrophobic interaction chromatography resin (e.g., any of the hydrophobic interaction chromatography resins described herein)); and collecting the retinoid, thereby isolating the retinoid.
- a chromatography system e.g., a chromatography system comprising a hydrophobic interaction chromatography resin (e.g., any of the hydrophobic interaction chromatography resins described herein)
- retinol can be selectively separated from farnesol using a chromatography system. Accordingly, provided herein are methods of isolating retinol from a composition including retinol and farnesol using a chromatography sy stem.
- the methods can include, for example, providing a composition including retinol and farnesol; feeding the composition into a chromatography system (e.g., a chromatography system comprising a hydrophobic interaction chromatography resin (e.g., any of the hydrophobic interaction chromatography resins described herein)); and collecting retinol, thereby isolating retinol.
- a chromatography system e.g., a chromatography system comprising a hydrophobic interaction chromatography resin (e.g., any of the hydrophobic interaction chromatography resins described herein)
- a hydrophobic interaction chromatography resin e.g., any of the hydrophobic interaction chromatography resins described herein
- retinoid e.g., retinol
- farnesol a composition comprising the retinoid (e.g., retinol) and farnesol prior to feeding the composition into a chromatography system.
- This filtration step can remove particulates in the liquid comprising the composition comprising the retinoid (e.g., retinol) and famesol that could clog or reduce the efficacy of the chromatography resin.
- a chromatography system can include one or more chromatography resins and/or one or more chromatography columns.
- the chromatography system can include a hydrophobic interaction chromatography resin (e.g., any of the hydrophobic interaction chromatography resins described herein) or a reverse-phase chromatography resin (e.g., any of the reverse-phase chromatography resins).
- Exemplary chromatography resins include PuroliteTM PCG600 (polystyrenic macroporous adsorbent non-functionahzed resm), Mitsubishi DiaionTM HP20SS (styrene-DVB porous adsorbent resin), PuroliteTM PCG1200 (polystyrenic macroporous adsorbent non-functionahzed resin).
- Non-limiting examples of hydrophobic interaction chromatography resins useful in the methods described herein can include those having a particle size of about 50 pm to about 900 pm (e.g., about 50 pm to about 600 pm, 50 pm to about 500 pm, 50 pm to about 200 pm, about 50 pm to about 150 pm, about 50 pm to about 100 pm, about 50 pm to about 80 pm, about 60 pm to about 600 pm, about 60 pm to about 500 pm, about 60 pm to about 200 pm, about 60 pm to about 180 pm, about 60 pm to about 120 pm, about 60 pm to about 100 pm, about 60 pm to about 80 pm, about 100 pm to about 600 pm, about 100 pm to about 500 pm, about 100 pm to about 200 pm, about 100 pm to about 150 un, about 200 un to about 600 pun, about 200 pun to about 500 pun, or about 500 pun to about 600 pun).
- a particle size of about 50 pm to about 900 pm e.g., about 50 pm to about 600 pm, 50 pm to about 500 pm, 50 pm to about 200 pm, about 50 pm to about 150 pm,
- Hydrophobic interaction chromatography resins can have a porosity of about 50 angstrom to about 500 angstrom (e.g., about 50 angstrom to about 200 angstrom, about 50 angstrom to about 100 angstrom, about 75 angstrom to about 250 angstrom about 75 angstrom to about 100 angstrom, about 100 angstrom to about 350 angstrom, about 100 angstrom to about 250 angstrom, about 100 angstrom to about 200 angstrom, or about 100 angstrom to about 150 angstrom).
- angstrom to about 500 angstrom e.g., about 50 angstrom to about 200 angstrom, about 50 angstrom to about 100 angstrom, about 75 angstrom to about 250 angstrom about 75 angstrom to about 100 angstrom, about 100 angstrom to about 350 angstrom, about 100 angstrom to about 250 angstrom, about 100 angstrom to about 200 angstrom, or about 100 angstrom to about 150 angstrom.
- the chromatography system comprises a simulated moving bed chromatography.
- the simulated moving bed chromatography can be performed continuously over a period of at least 3 days (e.g., at least 7 days, at least 14 days, at least 20 days, at least 60 days, or at least 90 days).
- a cycle of chromatography can vary depending on the specific biophysical properties of a target of interest (e.g., retinol), the chromatography resin(s), and mobile phases.
- a hydrophobic chromatography column can include the steps of loading a hydrophobic interaction chromatography column with a fluid including a retinoid (e.g., retinol) and farnesol, washing the column to remove unwanted biological material (e.g., contaminating proteins and/or small proteins), eluting the retinoid (e.g., retinol) bound to the column, and re-equilibrating the column.
- a retinoid e.g., retinol
- any of the single steps in a chromatography cycle can include one or more mobile phases (e g., two or more mobile phases), and one or more of any of the single steps in a chromatography cycle can include a mobile phase gradient.
- the chromatography system includes two or more (three or more, four or more, five or more, or six or more) cycles of chromatography.
- a retinoid e.g., retinol
- processes for isolating a retinoid include providing a composition including a retinoid (e.g., retinol) and famesol that is substantially free of fermentation broth, cells, cell debris, pollutants, and/or impurities.
- the process can include continuously feeding a liquid comprising the retinoid (e.g.
- a simulated moving bed chromatography system with least one hydrophobic interaction chromatography resin (e g., PuroliteTM PCG600 (polystyrenic macroporous adsorbent non-functionalized resin), Mitsubishi DiaionTM HP20SS (styrene-DVB porous adsorbent resin), PuroliteTM PCG1200 (polystyrenic macroporous adsorbent non-functionalized resin), and wherein the process runs continuously from the liquid comprising the retinoid (e.g., retinol) and farnesol to an eluate from the simulated moving bed chromatography that comprises isolated retinoid (e.g., retinol).
- retinoid e.g., retinol
- farnesol eluate from the simulated moving bed chromatography that comprises isolated retinoid (e.g., retinol).
- the processes described herein provide continuous and time-efficient production of a purified retinoid (e.g., purified retinol) from a liquid including a retinoid (e.g., retinol) and farnesol.
- a purified retinoid e.g., purified retinol
- a retinoid e.g., retinol
- farnesol farnesol
- compositions and Administration of Compositions are Compositions and Administration of Compositions
- compositions e.g., cosmetic compositions, pharmaceutical compositions
- a retinoid produced by any of the methods and processes described herein can be in the form of a liquid, semi -liquid, or solid.
- the compositions can be formulated for oral administration, topical administration, or intravenous administration. In some instances, the composition is formulated as a sublingual drop, a gel capsule, or a spray.
- the compositions are administered in a manner compatible with the dosage formulation.
- a pharmaceutical composition can include a pharmaceutically acceptable carrier and/or an excipient.
- a pharmaceutical carrier can include any solvents, dispersion media, coatings, adjuvants, stabilizing agents, diluents, preservatives, antibactenal and antifungal agents, isotonic agents, adsorption delaying agents, and the like.
- the composition is a lyophilized composition.
- adjuvants include aluminum hydroxide, aluminum phosphate, saponins, water-in-oil emulsions, oil-in-water emulsions, and water-in-oil-in- water emulsion.
- Non-limiting examples of diluents include water, saline, dextrose, ethanol, glycerol, and the like.
- Non-limiting examples of isotonic agents include sodium chloride, dextrose, mannitol, sorbitol, and lactose.
- Solvent extraction was performed by mixing the crude oil from liquid-liquid centrifugation with a solvent extraction system to selectively extract retinol from the oil phase. Ethanol was used a solvent in these experiments. Screening of conditions for solvent extraction were conducted to determine the recovery yield at vary ing solvent/oil ratio and ethanol concentrations For each bench-scale experiment about 10 g of oil and ethanol/water mixture were combined in a 20 mL amber vial at the conditions described in Table 1. Samples were mixed for 30 minutes at 410 rotations per minute (rpm) at ambient temperature ( ⁇ 20 °C), then centrifuged at 3000 rpm for 15 minutes. The resulting oil and solvent layer were assayed for retinol quantification. The highest retinol recovery from oil layer was found with mass ratio 5: 1 solvent/oil and ethanol concentrations > 90 wt%.
- a larger quantity of solvent extraction product was generated by combining 0.5kg crude oil and 90 wt% ethanol at 5:1 in an amber colored bottle and mixed using a stirring plate at 300-1000 rpm for at least 30 minutes at 20°C.
- the colored bottled was used to prevent retinol degradation by light exposure.
- the mixture was transferred to a settling tank to decant for 1-3 hours.
- the heavy phase, which contained the oil was drained from the bottom of the vessel and the light phase, containing the ethanol/water and solvent mixture, was collected as a product. Results are shown in Table 2A.
- the process was scaled to 1.5 kg of crude oil mixed with 90 wt% ethanol at 5: 1 in a tank with overhead stirrer (Table 2A).
- retinol purification was achieved by solvent removal by evaporation at low temperature (less than or equal to 50°C) to avoid retinol degradation. Finally, the evaporation product was blended with sunflower oil to obtain the final desired formulation concentration (FIG. 1).
- thermostability' of retinol in crude oil during evaporation This example demonstrates the thermostability' of retinol in crude oil during evaporation.
- the crude oil generated from solid-liquid centrifugation and liquid-liquid centrifugation of the fermentation broth and overlay was used as the starting material for the following experiment.
- the peak area percentage of all-trans retinol was 96%. After 8 minutes at 70°C, the peak area percentage of all-trans retinol was 95. 1% After 16 minutes at 70°C, the peak area percentage of all-trans retinol was 94.1%. After 24 minutes at 70°C, the peak area percentage of all-trans retinol was 93.1%; and after 48 minutes at 70°C, the peak area percentage of all-trans retinol was 90. 1%.
- thermostability of retinol during recovery by short path evaporation This example demonstrates thermostability of retinol during recovery by short path evaporation.
- the evaporation product was found to contain 82.3% peak area all-trans retinol. After 2.5 minutes at 200°C and 20 minutes at 125°C the evaporation product was found to contain 98. 1% and 94.5% peak area all-trans retinol, respectively. At 50°C no significant degradation was observed under the time interval of the experiments (i. e. , between 0-240 minutes at 50 °C).
- feed material was systematically added over the course of the run without removing any feed material.
- batch feeding no feed material was added or removed over the course of the run.
- the feed mass was divided in small fractions for separate batch evaporations.
- the concentrated intermediates were then combined for a final evaporation.
- Trans-retinol is know n to be thermally labile. Thermal exposure can degrade transretinol into cis isomers.
- the last step in the production of retinol was evaporation of retinol from polished crude oil in high-oleic sunflower oil (HOSUN).
- HOSUN high-oleic sunflower oil
- a process of extracting the retinol into a solvent and then evaporating the solvent off was performed (FIG. 6). It was discovered that a solvent flash could be operated at a much lower temperature than overhead evaporation of retinol, thereby resulting in a much lower thermal degradation of retinol.
- WFE wiped film evaporator
- Ethanol was tested as the preferred solvent because it is volatile, readily dissolved retinol in concentrated form, exhibited a clean phase separation from HOSUN high oleic sunflower oil, and was globally available in non-genetically modified organism (GMO), kosher, and organic grade. Crude oil, which had been polished by centrifugation and then flashed to reduce water content, was tested as the crude oil feed at three solvent feed: oil extraction ratios : 5 : 1 , 3 : 1 , and 1 :1. Experiments were performed first in a glovebox to minimize the amount of moisture taken up in the solvent, and then outside of the glovebox to mimic conditions more suitable for scale-up to manufacturing.
- GMO non-genetically modified organism
- Gloveboxes maintain inert atmosphere (less than 1 ppm oxygen and moisture) either by removing the moisture and oxygen from the inert atmosphere of a glovebox or by constant purging of the glovebox with a positive pressure of inert gas.
- Table 6 outlines the relevant experimental conditions.
- FIGs. 8A and 8B showed a positive correlation between ethanol: feed ratio and both retinol and BHT yields. These experiments also showed that yields were comparable between glovebox and out of glovebox handling.
- FIG. 9 showed a positive correlation between the ethanol extraction ratio and the BHT: retinol ratio, suggesting that a lower extraction ratio was more selective for retinol over BHT. Therefore, a lower extraction ratio was desirable to meet the BHT : retinol specification as defined in Table 8.
- Experiments performed within the glovebox had a slightly higher starting ratio (0.266) than experiments performed outside of the glovebox (0.259). However, this difference is believed to be negligible for scale-up manufacturing. Because there was little difference between glovebox and out of glovebox handling, it was determined that experiments could be performed at normal atmosphere.
- crude oil (A or B, containing 171 g/kg and 258g/kg of retinol, respectively) was mixed with ethanol/water solution (80%, 85%, 90% and 95% ethanol) at a defined ratio solvent oil (1 :1, 5: 1 and 9: 1) to reach a total mass of 10g.
- the mixture was centrifuged at 5000 rpm for 30 minutes. The final solvent and oil layers were recovered and analyzed for retinol titer to calculate process yield.
- Ethanol sources may contain additives (e.g., denaturants) that make ethanol unsafe for consumption while still being acceptable for other uses.
- Undenatured ethanol is an example of an ethanol that is free of additives.
- Crude oil was mixed with 90: 10 v/v ethanol/water at a ratio of 1 :5 wt oil/solvent.
- Table 10 provides the list of ethanol solutions that were tested.
- the total volume of each ethanol solution was approximately 250 rnL.
- each ethanol solution was mixed for at least 30 minutes.
- the ethanol solution was poured into a separation funnel to decant for more than 2 hours.
- the oil layer and the solvent layer were separated and analyzed for retinol concentration.
- retinol yield obtained in Table 10 denaturants are effective for use in retinol extraction from crude oil. All of the tested ethanol solutions - which varied depending on the mixture of denaturants - had a retinol yield of at least 70%. The highest retinol yield was obtained in an ethanol solution comprising >90% ethanol, between 3-5% methanol, between 1-5% ethyl acetate and between 1-5% 4-methylpentan-2-one.
- This example demonstrates the separation of retinol from famesol, a C15 sesquiterpene alcohol (C15H26O).
- Famesol can be a by-product from fermentation and an undesirable impurity for cosmetic applications.
- Retinol and farnesol are structurally similar, which makes their separation challenging.
- the thermal instability of retinol limits the possibility of separation of retinol and farnesol by evaporation, as illustrated in Example 2 and Example 3.
- Chromatography using hydrophobic adsorbents was found to be an efficient and scalable process for retinol/famesol resolution. Screening of hydrophobic resins was conducted to evaluate retinol/famesol separation and guided the choice of process conditions.
- a 0.5 mL reference solution containing 1 wt% retinol, 1 wt% farnesol and 0.01 wt% butylated hydroxy toluene (BHT) in 90/10 vol% ethanol/water was injected into each column (ID 1.6cm) packed with 15 g of resin and preconditioned at 90/10 vol% ethanol/water.
- the columns were then washed with 40/60 vol% ethanol/water over 3 bed volumes (BV), eluted with the gradient 40-100 vol% ethanol over 20 BV, and flushed with 100% ethanol over 5 BV.
- the wash and elution flowrates were set at 2 BV/hour.
- Retinol and farnesol peaks were identified by absorbance at 325 and 200 nm, respectively. Resulting chromatograms are shown in FIGs. 4A-C. The elution volumes at mid peak are indicated in Table 11 for three exemplary resins, Diaion HP20SS, PuroliteTM PCG600, and PuroliteTM PCG950, that resulted in clear retinol/famesol resolution. Hydrophobic adsorbents DiaionTM HP20, SepabeadsTM SP70, SepabeadsTM SP700 and SepabeadsTM SP207 are examples of resins that did not results in efficient retinol/famesol resolution in the abovementioned conditions.
- Ethanol solvent extract solutions containing 2.6 - 3.1 wt% retinol and 1.4 - 2.4 wt% famesol/retinol ratio were produced as described in Example 1.
- the solvent extraction was then followed by a filtration step, a chromatography step for product purification, solvent evaporation and blending steps (FIG. 5).
- the solvent layer of the solvent extraction w as filtered using a 0.45 microns filter media to remove any remaining cell debris that could impact chromatography performance.
- the permeate was pumped into a column (ID 1.6 cm) packed with Diaion HP20SS (Mitsubishi Chemical) pre-conditioned at 90/10 vol% ethanol/water.
- the column was first washed with 5 BV of 70/30 vol% ethanol/water and then eluted with 5 BV of 85/15 vol% ethanol/water and 5 BV of 96/4 vol% ethanol/water. Finally, the column was flushed with 100% ethanol over 5 BV.
- the elution concentration profiles of both retinol and famesol were determined by HPLC analysis of chromatography fractions.
- the product cut i.e., purified retinol
- Two columns with different bed heights were evaluated over a range of resin loadings (0.5 - 2.5 wt% retinol fed into column/resin).
- Column details and performance results are shown in Table 12.
- the feed was a solvent extraction product containing 2.5wt% retinol and 1 .6 wt% Famesol/Retinol ratio.
- the packed chromatography column (bed height 14 cm, bed volume (BV) 28 mL) contained 15 g of Diaion HP20SS resin.
- the column was equilibrated with 90% ethanol before loading feed solution at 2% retinol/resin. Then the column was washed with 5 BV of 70/30 vol% ethanol/water and the target molecule eluted with 5 BV of 85/15 vol% ethanol/water. Then 5 BV of 95/5 vol% ethanol/water were applied to strip more hydrophobic components.
- the column was cleaned between each cycle with 5 BVs of isopropyl alcohol.
- the process may vary in wash, elution and strip conditions for different yield, purity and solvent consumption.
- the feed was a solvent extraction product containing 2 wt% retinol and 1.9 wt% Famesol/Retmol ratio.
- the packed chromatography column (bed height 24 cm, bed volume (BV) 48 mL) contained 23 g of Diaion HP20SS resin.
- the column was equilibrated with 90% ethanol before loading feed solution at 2% retinol/resin. Wash, elution and strip steps conditions are described in Table 14.
- the column was cleaned after each cycle with 5 BVs of isopropyl alcohol.
- Table 14 Exemplary experimental results for farnesol removal by varying wash and elution conditions
- Chromatography process can partially or totally separate the antioxidant (e.g. BHT, Tocobiol®, or Tocobiol® SF ER) from retinol.
- an antioxidant e.g., BHT, Tocobiol®, or Tocobiol® SF ER, or any of the antioxidants described herein
- BHT BHT, Tocobiol®, or Tocobiol® SF ER, or any of the antioxidants described herein
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Provided herein are methods of isolating a retinoid that includes: providing a fermentation broth comprising the retinoid and an overlay; performing a liquid-solid and liquid-liquid separation on the fermentation broth to produce a crude oil and a waste heavy phase; mixing the crude oil with a solvent extraction system to extract the retinoid from the crude oil; and stripping the solvent extraction system from the extracted retinoid to thereby isolate the retinoid. Also provided herein are methods of isolating a retinoid from a composition including the retinoid and farnesol that include: providing a composition including the retinoid and farnesol; feeding the composition into a chromatography system; and collecting the retinoid, thereby isolating the retinoid.
Description
METHODS OF BIOMANUFACTURING AND PURIFYING RETINOIDS
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims priority to U.S. Provisional Patent Application No. 63/374,274, filed on September 1, 2022, the entire contents of which is herein incorporated by reference in its entirety.
TECHNICAL FIELD
This invention relates to methods of biomanufacturing and purifying retinoids.
BACKGROUND
Retinoids, in particular all-trans retinol, has been widely used in the cosmetic industry for its anti-aging properties and as a supplement to treat vitamin A deficiency. Commercially available retinol has been chemically synthesized. One known limitation of chemically synthesizing retinol is the cost and yield. Fermentation can be a cheaper alternative to chemical synthesis, and provides the opportunity to produce and purify retinol at large scale.
SUMMARY OF THE INVENTION
Provided herein are methods of isolating a retinoid that include: providing a fermentation broth comprising the retinoid and an overlay ; performing a liquid-solid and a liquid-liquid separation on the fermentation broth to produce a crude oil and a waste heavy phase; mixing the crude oil with a solvent extraction system to extract the retinoid from the crude oil; and stripping the solvent extraction system from the extracted retinoid to thereby isolate the retinoid.
In some embodiments, the solvent extraction system comprises ethanol, isopropyl alcohol (IP A), acetone, or propanediol, or a combination thereof. In some embodiments, the solvent extraction system comprises about 70 wt% to about 99.95 wt% ethanol.
In some embodiments, the solvent extraction system comprises acetic acid, acetonitrile, methanol, n-propanol, methyl acetate, ethyl acetate, n-hexane, cyclohexane, or n- heptane.
In some embodiments, the solvent extraction system includes ethanol, wherein the ethanol is free of additives. In some embodiments, the ethanol free of additives is a denatured ethanol.
In some embodiments, the solvent extraction system includes ethanol and isopropyl alcohol. In some embodiments, the solvent extraction system includes between about 90% and about 99% (e.g., about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, or about 99%) ethanol and between about 1% and about 10% (e.g., about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, or about 10%) isopropyl alcohol. In some embodiments, the solvent extraction system includes about 95% ethanol and about 5% isopropyl alcohol.
In some embodiments, the solvent extraction system includes ethanol and n-heptane. In some embodiments, the solvent extraction system includes between about 90% and about 99% (e.g., about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, or about 99%) ethanol and between about 1% and about 10% (e.g., about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about 7%, about 8%, about 9%, or about 10%) n-heptane. In some embodiments, the solvent extraction system includes about 95% ethanol and about 5% n-heptane.
In some embodiments, the solvent extraction system includes ethanol, methanol, ethyl acetate, and 4-methylpentan-2-one. In some embodiments, the solvent extraction system includes between about 90% and about 100% (e.g., about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, about 99%, or about 100%) ethanol, between about 3% and about 5% (about 3%, about 3.5%, about 4%, about 4.5%, about 4.6%, about 4.8%, about 4.9%, or about 5%) methanol, between about 1% and about 5% (e.g., about 1 %, about 1 .5%, about 2%, about 2.5%, about 3%, about 3.55, about 4%, about 4.5%, about 4.6%, about 4.8%, about 4.9%, or about 5%) ethyl acetate, between about 1% and about 5% (e.g., about 1%, about 1.5%, about 2%, about 2.5%, about 3%, about 3.55, about 4%, about 4.5%, about 4.6%, about 4.8%, about 4.9%, or about 5%) 4-methylpentan-2- one. In some embodiments, the solvent extraction system includes between about 90% and about 99% ethanol, between about 3% and about 4.5% methanol, between about 1% and about 4% ethyl acetate, and between about 1% and about 4% 4-methylpentan-2-one.
In some embodiments, the solvent extraction system includes between about 90% ethanol, about 3% methanol, about 1%, ethyl acetate, about 1% 4-methylpentan-2-one.
In some embodiments, the solvent extraction system comprises methylene chloride, ethyl ether, chloroform, or carbon tetrachloride.
In some embodiments, the water content in the solvent extraction system is between about 0% to about 60%.
In some embodiments of any of the methods described herein, the mass ratio of the solvent extraction system to crude oil ranges from about 10: 1 to about 100:1.
In some embodiments of any of the methods described herein, the mass ratio of the solvent extraction system to crude oil ranges from about 1 : 1 to about 5: 1.
In some embodiments, the overlay comprises a mineral oil and/or a vegetable oil.
In some embodiments, the overlay comprises mineral oil, and the mineral oil is Durasyn® 164 polyalphaolefin or Drakeol® 10.
In some embodiments, the overlay comprises vegetable oil, and the vegetable oil is butter, bisabolol oil, canola oil, castor oil, cocoa butter, coconut oil, cod liver oil, com oil, cottonseed oil, grape seed oil, jojoba oil, kapok seed oil, linseed oil, olive oil, palm kernel oil, palm oil, patchouli oil, peanut oil, poppyseed oil, rapeseed oil, rice bran oil, safflower oil, soybean oil, sunflower oil, tung oil, walnut oil, or wheat germ oil, or a mixture thereof.
In some embodiments, the liquid-liquid separation comprises centrifugation, filtration with a functionalized membrane, tangential flow filtration, and/or sedimentation.
In some embodiments, the stripping the solvent extraction system comprises decanting for about 30 minutes to about 24 hours. In some embodiments, stripping the solvent extraction system comprises evaporation or fractional distillation. In some embodiments, the solvent evaporation is performed in a single step. In other embodiments, the solvent evaporation is performed in multiple steps (e.g., two, three, four, five, or six steps).
In some embodiments, the solvent evaporation includes a rising-film evaporator, a falling-film evaporator, a wiped film evaporation, an agitated thin film, or a plate.
In some embodiments, the solvent evaporation is performed in two-steps. In some embodiments, the solvent evaporation is performed in two-steps with recirculation or without recirculation.
In some embodiments, stripping the solvent extraction system comprises evaporating the solvent at a temperature of less than about 50 °C. In some embodiments, stripping the solvent extraction system comprises evaporating solvent at a temperature of about 50 °C to about 200 °C.
In some embodiments, the method further includes feeding the isolated retinoid into a chromatography system comprising a hydrophobic interaction chromatography resin or a reverse-phase chromatography resin. In some embodiments, the hydrophobic interaction chromatography resin is a hydrophobic interaction chromatography resin with a particle size of about 63 pm to about 150 pm. In some embodiments, the method further includes filtering the isolated retinoid prior to feeding the isolated retinoid into the chromatography system. In
some embodiments, the method further includes evaporating solvent at a temperature less than 50 °C.
In some embodiments of any of the methods described herein, the method further includes adding a high oleic oil thereby producing a cosmetic composition. In some embodiments, the high oleic oil is a high oleic organic sunflower oil. In some embodiments of any of the methods described herein, the retinoid is retinol.
Provided herein are methods of isolating a retinoid from a composition comprising the retinoid and farnesol that include: providing a composition comprising the retinoid and famesol; feeding the composition into a chromatography system; and collecting the retinoid, thereby isolating the retinoid.
In some embodiments, the chromatography system comprises a hydrophobic interaction chromatography resin or a reverse-phase chromatography resin.
In some embodiments, the hydrophobic interaction chromatography resin is a hydrophobic interaction chromatography resin with a particle size of about 63 pm to about 150 pm. In some embodiments, the chromatography resin is Purolite™ PCG600, Mitsubishi Diaion™ HP20SS, Purolite™ PCG1200.
In some embodiments, the method further includes filtering the isolated retinoid prior to feeding the composition into the chromatography system. In some embodiments, the method further includes evaporating solvent at a temperature less than 50 °C. In some embodiments, the method further includes adding a high oleic oil thereby produce a cosmetic composition. In some embodiments, the high oleic oil is a high oleic organic sunflower oil.
Provided herein are compositions including the retinoid produced by any of the methods described herein. In some embodiments, the composition is a liquid or a semiliquid. In some embodiments, the composition is formulated for oral administration, topical administration, or intravenous administration. In some embodiments, the composition is formulated as a sublingual drop, a gel capsule, or a spray.
Also provided herein are cosmetic compositions and pharmaceutical compositions including the retinoid produced by any of the methods described herein. In some embodiments of any of the pharmaceutical compositions described herein, the pharmaceutical composition includes a pharmaceutically acceptable carrier and/or excipient. In some embodiments of any the pharmaceutical compositions described herein, the pharmaceutically acceptable carrier and/or excipient is an adjuvant.
Provided herein are compositions including a retinoid, wherein the retinoid is produced by a method including: a) culturing a population of host cells that are genetically
modified to express one or more enzymes of a retinoid biosynthetic pathway in a culture medium and under conditions suitable for the population of host cells to produce the retinoid, thereby producing a fermentation composition; and b) recovering the retinoid from the fermentation composition, wherein the retinoid is present in the composition with a purity of between 40% w/w and 99.9% w/w (e.g., between 40% w/w and 90% w/w, between 40% w/w and 80% w/w, between 40% w/w and 70% w/w, between 50% w/w and 99.9% w/w, between 50% w/w and 90% w/w, between 50% w/w and 80% w/w, between 50% w/w and 70% w/w, between 60% w/w and 99.9% w/w, between 60% w/w and 90% w/w, between 60% w/w and 80% w/w, between 80% w/w and 99.9% w/w, or between 90% w/w and 99.9% w/w).
Provided herein are methods of isolating a retinoid that include: a) culturing a population of host cells that are genetically modified to express one or more enzymes of a retinoid biosynthetic pathway in a culture medium and under conditions suitable for the population of host cells to produce the retinoid, thereby producing a fermentation composition; and b) recovering the retinoid from the fermentation composition, wherein the retinoid is present in the composition with a purity of between 40% w/w and 99.9% w/w (e.g., between 40% w/w and 90% w/w, between 40% w/w and 80% w/w, between 40% w/w and 70% w/w, between 50% w/w and 99.9% w/w, between 50% w/w and 90% w/w, between 50% w/w and 80% w/w, between 50% w/w and 70% w/w, between 60% w/w and 99.9% w/w, between 60% w/w and 90% w/w, between 60% w/w and 80% w/w, between 80% w/w and 99.9% w/w, or between 90% w/w and 99.9% w/w).
The term “solvent extraction system” refers to one or more component(s) that are used in a process by which a composition comprising a retinoid (e.g., retinol) (e.g., a fermentation broth comprising a retinoid (e.g., a fermentation broth comprising retinol), a liquid compnsing a retinoid (e.g. ,a liquid comprising retinol), or a crude oil containing a retinoid (e.g., a crude oil containing retinol)) is separated, based on physiochemical properties (e.g., solubility or distribution coefficient), into two or more (e.g., 2, 3, or 4, or more) different immiscible phases. In one embodiment, solvent extraction removes retinol from oil (overlay) to the solvent phase. A solvent extraction system may include a single solvent, or a mixture of solvents. Non-limiting examples of solvents include: ethanol, isopropyl alcohol (IP A), acetone, or propanediol, acetic acid, acetonitrile, methanol, n-propanol, methyl acetate, ethyl acetate, n-hexane, cyclohexane, n-heptane, methylene chloride, ethyl ether, chloroform, carbon tetrachloride, and isohexane. The selection of a particular solvent can depend, for
example, on its distribution coefficient, selectivity, (in)solubility, recoverability, viscosity, vapor pressure, thermostability, toxicity, allergenic properties, availability, and/or cost.
The term “solvent evaporation” refers to the step(s) in which the solvent is removed from a retinoid (e.g., retinol) by evaporation. Solvent evaporation can be performed in a single step or in multiple steps in series. Non-limiting examples solvent evaporation include use of a tank or tubular, rising-film evaporator (RFE), falling-film evaporator, wiped film evaporation (WFE), agitated thin film, or a plate. Each of these methods of solvent evaporation can be performed as a single pass or multiple passes. In some embodiments, solvent evaporation requires the presence of stream recirculation. In other embodiments, solvent evaporation does not require stream recirculation. In some embodiments, the solvent evaporation occurs in batch mode. In some embodiments, the solvent evaporation occurs in fed-batch mode. In some embodiments, the solvent evaporation is continuous.
The term “clarified fermentation broth” means a fermentation broth obtained from a cell culture that is substantially free of cells (e.g., whole bacteria, or whole yeast cells).
The term “substantially free” refers to a composition (e.g., a purified product) that is at least about 80% free (e.g., at least about 85%, 90%, 95%, 96%, 97%, 98%, or 99% free) of a specified substance (e.g., famesol).
The term “liquid-liquid separation” is known in the art and refers to any liquid-liquid separation technique that partially or fully separates one or more liquid phases that are immiscible (e.g., one or more oils (e.g., 1, 2, 3 oils) and/or combinations of one or more oils and one or more solvents (e.g., two solvents) from a waste heavy phase. A liquid-liquid separation can demulsify an emulsion (e.g., an emulsion and aqueous phase, an oil and emulsion). Non-limiting examples of liquid-liquid separation include use of a decanter, a solvent, or a combination thereof.
The term “purifying” means performing at least one step to isolate a retinoid (e.g., retinol) from one or more other impurities (e.g., bulk impurities, whole cell debris, and/or famesol) and/or components present in a liquid that comprises a retinoid (e.g., retinol) (e.g., a clarified fermentation broth comprising a retinoid (e.g., a clarified fermentation broth comprising retinol), or a crude oil), or one or more other components (e.g., DNA, RNA, other proteins, endotoxins, viruses etc.) present in or secreted from cells within a fermentation broth.
The term “filter(ing)” refers to the removal of at least some (e.g., at least 80%, 90%, 95%, 96%, 97%, 98%, or 99%) undesired biological contaminants (e.g., a cell), and/or
solvents, from a liquid that comprises a retinoid (e.g., retinol) (e.g., a clarified fermentation broth comprising a retinoid (e.g., retinol), or a crude oil).
The term “eluate” is a term of art and refers to a liquid that exits a chromatography column of a chromatography system that includes a detectable amount of a retinoid (e.g., retinol).
The term “continuous process” means a process that continuously feeds a liquid (e.g., a fermentation broth, a clarified fermentation broth, crude oil, a liquid comprising a retinoid (e g., retinol), and/or a composition comprising a retinoid (e g., retinol)) through at least a part of a process. For example, in any of the exemplary continuous processes described herein, a liquid comprising a retinoid (e.g., retinol) (e.g., a fermentation broth, a clarified fermentation broth, crude oil, a liquid comprising a retinoid (e.g., retinol), and/or a composition comprising a retinoid (e.g., retinol)) is continuously fed into the process while it is in operation and an eluate comprising the retinoid (e.g., retinol) is fed out of the process.
The term “closed process” is a term of art that means a process that is performed such that components of the process (e.g., liquid-liquid separation, solvent extraction system, chromatography system) that come into contact with a retinoid (e.g., retinol) are not intentionally exposed to contaminating agents for a significant period of time (e.g., not intentionally air-exposed for a significant period of time).
The term “chromatography system” means a system that includes one or more interconnected or switching chromatography columns and/or chromatographic membranes. A non-limiting example of a chromatography system is simulated moving bed chromatography. Additional examples of chromatography systems are described herein and are known in the art.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Methods and materials are described herein for use in the present invention; other, suitable methods and materials known in the art can also be used. The materials, methods, and examples are illustrative only and not intended to be limiting. All publications, patent applications, patents, sequences, database entries, and other references mentioned herein are incorporated by reference in their entirety. In case of conflict, the present specification, including definitions, will control.
Other features and advantages of the invention will be apparent from the following detailed description and figures, and from the claims.
DESCRIPTION OF DRAWINGS
FIG. 1 is an exemplary process flow diagram for extraction of retinol.
FIG. 2 shows the chemical structure of retinol.
FIG. 3 shows the chemical structure of famesol.
FIG. 4A is a chromatogram of gradient elution of a reference solution (1 wt% retinol, 1 wt% farnesol and 0.01 wt% (butylated hydroxytulene (BHT) in 90/10 ethanol/water solution) using a column packed with Diaion HP20SS (Mitsubishi Chemical). Retinol and farnesol were identified at wavelengths 325 nm and 200 nm, respectively.
FIG. 4B is a chromatogram of gradient elution of a reference solution (1 wt% retinol, 1 wt% famesol and 0.01 wt% (BHT) in 90/10 ethanol/water solution) using a column packed with Purolite PCG600. Retinol and farnesol were identified at wavelengths 325 nm and 200 nm, respectively.
FIG. 4C is a chromatogram of gradient elution of a reference solution (1 wt% retinol, 1 wt% famesol and 0.01 wt% (BHT) in 90/10 ethanol/water solution) using a column packed with Purolite PCG950. Retinol and farnesol were identified at wavelengths 325 nm and 200 nm, respectively.
FIG. 5 is an exemplary process flow diagram for isolation of retinol that includes steps of filtration, product purification, solvent evaporation, and blending after solvent extraction.
FIG. 6 is an exemplary process flow diagram showing an exemplary process for retinol extraction. Processes are shown in solid lines (e g , fermentation, liquid-solid centrifugation, liquid-liquid centrifugation, solvent extraction, evaporation, blend). Streams (e.g., light phase, heavy phase) are shown in dashed lines.
FIG. 7 is a schematic diagram showing one example of solvent extraction of retinol with two feed solutions: (A) Oil feed containing retinol and (B) solvent feed are the inputs and the outputs are (C) the oil layer and (D) the solvent extract. The solvent outlet is the main product, and contains most of the retinol at the end of the process.
FIG. 8A is a graph showing retinol yield (by loss) against ethanol: oil extraction ratios (1, 3, 4.5, and 5) within a glovebox and outside of a glovebox. Moisture and oxygen are removed from the inert atmosphere of a glovebox, which minimizes the amount of moisture that is taken up by the solvent (ethanol). Conditions outside of a glovebox mimic experimental conditions suitable for scale-up manufacturing.
FIG. 8B is a graph showing butylated hydroxytulene (BHT) yield (by loss) against ethanol: oil extraction ratios (1, 3, 4.5, and 5) within a glovebox and outside of a glovebox.
FIG. 9 is a graph showing BHT: retinol ratio in solvent phase against ethanol: crude oil extraction ratios (1, 3, 4.5, and 5) within a glovebox and outside of a glovebox.
FIG. 10 is a graph showing famesol/retinol in product [wt%] and retinol yield [%] following twenty two consecutive chromatography runs.
DETAILED DESCRIPTION
The present disclosure is directed, in part, to methods of isolating a retinoid (e.g., retinol), including, for example, from a fermentation broth or other liquid comprising a retinoid (e.g., retinol) or both a retinoid (e.g., retinol) and famesol. The methods can include, e.g., providing a fermentation broth comprising a retinoid (e.g., retinol); performing a liquidliquid separation on the fermentation broth to produce a crude oil and a waste heavy phase; mixing the crude oil with a solvent extraction system to extract the retinoid (e.g., retinol) from the crude oil; and stripping the solvent extraction system from the extracted retinoid (e.g., retinol) to thereby isolate the retinoid (e.g., retinol). Also provided herein are methods of isolating a retinoid (e.g., retinol) from a composition that includes a mixture of a retinoid (e.g., retinol) and famesol. The methods can include, for example, providing a composition including a retinoid (e.g., retinol) and farnesol; feeding the composition into a chromatography system; and collecting the retinoid (e.g., retinol), thereby isolating the retinoid (e.g., retinol) from the farnesol.
Non-limiting aspects of these methods of these methods are described below. As can be appreciated in the art, the various aspects described below can be used in any combination without limitation.
Retinol
Retinol or vitamin A alcohol (C20H30O) is the main circulating form of vitamin A found in plasma. Retinol has been shown to be involved in cellular differentiation and proliferation. Retinol or all-tra s -retinol is a 20-carbon molecule with a cyclohexenyl ring, a side chain with four double bonds (in trans configuration), and an alcohol end group (FIG. 2). Retinol has a molecular weight of 286.45 and has the following chemical structure:
Retinol is commercially available as a crystalline material with a melting point in the 62 °C to 64 °C range. Retinol is known to degrade with exposure to UV, oxygen, and temperature. Exposure to light is preferentially minimized during biomanufacturing, purification and experimentation. Retinol has been used extensively in a variety of antiaging cosmetic products as well as for treatment of skins disorders, such as acne, psoriasis, age spots, discoloration, and melasma. Retinol is used to reduce the effects of stress in skin and sun damage. It can also enhance cell turnover, promote collagen production, facilitate wound healing, and reduce wrinkles and fine lines. Since retinol is only naturally found in animal- derived products, such as milk, cheese, butter, and liver, it is also used as a dietary supplement for vitamin A deficiency (e.g., night blindness and xerophthalmia). Retinol is converted into retinal and retinoic acid.
Overall Process for Isolating A Retinoid from a Fermentation Broth
Provided herein are methods of isolating a retinoid (e.g., retinol). The methods can generally include the steps of providing a fermentation broth including a retinoid (e.g., retinol) and an overlay; performing a liquid-liquid separation on the fermentation broth to produce a crude oil and a waste heavy phase; mixing the crude oil with a solvent extraction system to extract retinoid (e.g., retinol) from the crude oil; and stripping the solvent extraction system from the extracted retinoid (e.g., retinol) to thereby isolate the retinoid (e.g., retinol).
A fermentation broth that includes a retinoid (e g., retinol) can be generated using any fermentation method employing microorganisms capable of producing a retinoid (e.g., retinol). Methods of genetically modifying microorganisms to produce proteins of interest are known in the art and can be used to modify or cause the expression of enzymes, such as those involved in the production of a retinoid (e.g., retinol), such that large quantities of a retinoid (e.g., retinol) are produced by the microorganisms. In some instances, antioxidants (e.g., BHT) may be added to the fermentation broth to increase the total fermentation efficiency and to prevent the oxidation of a retinoid to another product and other degradation products (e.g., to prevent the oxidation of retinol to retinal and other retinol degradation products).
Processes described herein can include adding an overlay to the fermentation broth. An overlay can, for example, create anaerobic conditions such that a retinoid (e.g., retinol) is not degraded during the isolation process. The overlay can include, e.g., a mineral oil and/or a vegetable oil. Exemplary mineral oils include, e.g., Durasyn® 164 polyalphaolefin or
Drakeol® 10 white mineral oil. Exemplary vegetable oils include butter, bisabolol oil, canola oil, castor oil, cocoa butter, coconut oil, cod liver oil, com oil, cottonseed oil, grape seed oil, jojoba oil, kapok seed oil, linseed oil, olive oil, palm kernel oil, palm oil, patchouli oil, peanut oil, poppyseed oil, rapeseed oil, rice bran oil, safflower oil, soybean oil, sunflower oil, tung oil, walnut oil, or wheat germ oil, or a mixture of at least two of any of such oils.
The liquid-solid separation can be performed using methods known to those of skill in the art. For example, liquid-liquid separation can include centrifugation, filtration with a functionalized membrane (e.g., hydrophobic membranes (e.g., polymeric hydrophobic membranes (e.g., PTFE (polytetrafluoroethylene), PDMS (poly dimethyl siloxane), POMS (poly octy lmethyl siloxane) or PEBA (polyether block amide))) and hydrophilic membranes (e.g., Silica-based membranes, zeolite membranes), tangential flow filtration, and/or sedimentation.
Liquid-solid separation can include a step of decanting to separate a liquid from a suspension of insoluble particles and biomass debris (e.g., microorganisms, bacteria, pollutants). For example, in some instances, decanting can be performed for about 30 minutes to about 24 hours (e.g., about 30 minutes to about 3 hours, about 1 hour to about 6 hours, about 1 hour to about 3 hours, or about 1 hour to about 2 hours).
Mixing the crude oil with a solvent extraction system can include, for example, mixing the crude oil with a solvent extraction system for about 5 minutes to about 3 hours (e.g., about 5 minutes to about 45 minutes, about 15 minutes to about 1 hour, or about 15 minutes to about 30 minutes). Tn some instances, mixing is carried out using rotary agitation. For example, mixing can be performed at a rotary agitation speed of about 300 rotations per minute (RPM) to about 1000 RPM (e.g., about 300 RPM to about 900 RPM, about 300 RPM to about 500 RPM, or about 500 RPM to about 1000 RPM).
A solvent extraction system is used to selectively extract a retinoid (e g., retinol) from the oil phase of a crude oil containing the retinoid (e.g., retinol). Skilled practitioners will appreciate that a number of different solvent extraction systems can be selected, depending on the desired outcome and the conditions under which the extraction will be performed. The solvent extraction system can include one or more of acetic acid, acetonitrile, methanol, ethanol, acetone, isopropanol, n-propanol, methyl acetate, ethyl acetate, methylene chloride, ethyl ether, chloroform, carbon tetrachloride, n-hexane, isohexane, denatured ethanol, cyclohexane, n-heptane, and mixtures of any two or more of such compositions. In some instances, the solvent extraction system does not include one or more solvents, e.g., in some instances the solvent extraction system may specifically not include methylene chloride, ethyl
ether, chloroform, carbon tetrachloride, or a combination thereof. A particularly useful solvent extraction system for use in the presently described methods include ethanol (EtOH), isopropyl alcohol (IP A), acetone, propanediol, or any combination thereof.
In addition to selecting a solvent extraction system, it is important to select the conditions for use of the solvent extraction system to maximize the extraction yield. Both the water content in the solvent/water mixture of the solvent extraction system and the mass ratio of the solvent extraction system to crude oil can play an important role in maximizing extraction yield and will vary depending on the solvent extraction system and overlay. For example, solvent extraction systems described herein can include a water content in the solvent/water mixture of about 0% to about 60% (e.g., about 1% to about 25, about 1% to about 45%, about 1% to about 60%, about 5% to about 45%, about 5% to about 30%, about 10% to about 25%, about 25% to about 60%, or about 30% to about 50%). In some embodiments, the solvent extraction system includes ethanol at about 70 wt% to about 99.95 wt% (e.g., about 70 vt% to about 95 wt%, about 80 wt% to about 99% wt%, about 80 wt% to about 95 wt%, about 90 wt% to about 99% wt%, about 90 wt% to about 95 wt%, or about 90 wt% to about 92 wt%). For example, the mass ratio of any of the solvent extraction systems described herein to crude oil can range from about 10: 1 to about 100: 1 (e.g., about 10: 1 to about 80:1, about 10: 1 to about 50: 1, about 10: 1 to about 20:1, about 20:1 to about 100: 1, about 20:1 to about 50: 1, about 50: 1 to about 100: 1, about 70: 1 to about 100:1, or about 80: 1 to about 100: 1). In some instances, the mass ratio of the solvent extraction system to crude oil ranges from about 1 : 1 to about 5:1 (e g., about 1 : 1 to about 4: 1 , about 1 : 1 to about 3: 1 , about 1: 1 to about 2:1, , about 2: 1 to about 4: 1, about 3: 1 to about 4: 1, e.g., about 1: 1, about 2: 1, about 3: 1, about 4: 1, or about 5: 1).
In order to further separate a retinoid (e.g., retinol) from components found within the solvent extraction system and for future downstream processes and use of the isolated retinoid (e.g., retinol), the solvent extraction system may be stripped. Stripping of the solvent extraction system is useful to separate more than two types of components from each other in an otherwise homogenous mixture. Stripping the solvent extraction system can include evaporation or fractional distillation. For example, stripping the solvent extraction system can include evaporating solvent at a temperature of about 50 °C to about 200 °C (e.g., about 50 °C to about 180°C, about 50 °C to about 120°C, about 50 °C to about 100 °C, about 75 °C to about 200 °C, about 75 °C to about 100 °C, about 100 °C to about 200 °C, about 100 °C to about 180 °C, about 100 °C to about 150°C, about 100 °C to about 120 °C, about 150°C to about 200 °C, or about 150 °C to about 180 °C). Depending on the solvent, stripping the
solvent extraction system can include, e.g., evaporating the solvent at a temperature of less than about 50 °C (e.g., between about 20 °C to about 48 °C, between about 20 °C to about 45 °C, or between about 20 °C to about 30 °C).
Retinol can optionally be separated from famesol before the solvent system is removed. Farnesol has the following chemical structure:
Because of the chemical similarities between retinol and famesol, farnesol is not readily separated from retinol using evaporation without resulting in at least some retinol degradation. However, farnesol and retinol can successfully be separated using a chromatography system. Without wishing to be bound by theory, it was found that the isolated retinol, when fed into a chromatography system comprising a hydrophobic interaction chromatography resin (e.g., any of the hydrophobic interaction chromatography resins described herein) or a reverse-phase chromatography resin (e.g., any of the reversephase chromatography resins), can selectively be isolated from farnesol, which is a byproduct from fermentation and an undesirable impurity for cosmetic applications. Exemplary chromatography resins include Purolite™ PCG600 (polystyrenic macroporous adsorbent non-functionalized resin), Mitsubishi Diaion™ HP20SS (styrene-DVB porous adsorbent resin), Purolite™ PCG1200 (polystyrenic macroporous adsorbent non-functionalized resin).
In some instances, the liquid comprising the isolated retinoid (e.g., retinol) may be filtered prior to feeding the isolated retinoid (e.g., retinol) into a chromatography system. This filtration system removes particulates in the liquid containing the isolated retinoid (e.g., retinol) that could clog or reduce the efficacy of the chromatography resin.
In some instances, a hydrophobic interaction chromatography can be used. A hydrophobic interaction chromatography resin can include a particle size of about 50 pm to about 900 pm (e.g., about 50 pm to about 600 pm, about 50 pm to about 500 pm, about 50 pm to about 200 pm, about 50 pm to about 150 pm, about 50 pm to about 100 pm, about 50 pm to about 80 pm, about 60 pm to about 600 pm, about 60 pm to about 500 pm, about 60 pm to about 200 pm, about 60 pm to about 180 pm, about 60 pm to about 120 pm, about 60 pm to about 100 pm, about 60 pm to about 80 pm, about 100 pm to about 600 pm, about 100 pm to about 500 pm, about 100 pm to about 200 pm, about 100 pm to about 200 pm, about 100 pm to about 150 pm, about 200 pm to about 600 pm, about 200 pm to about 500 pm, or about 500 pm to about 600 pm). The hydrophobic interaction chromatography resins can, for
example, have a porosity of about 50 angstrom to about 500 angstrom (e.g., about 50 angstrom to about 200 angstrom, about 50 angstrom to about 100 angstrom, about 75 angstrom to about 250 angstrom about 75 angstrom to about 100 angstrom, about 100 angstrom to about 350 angstrom, about 100 angstrom to about 250 angstrom, about 100 angstrom to about 200 angstrom, or about 100 angstrom to about 150 angstrom).
Skilled practitioners will appreciate that in some instances, methods described herein can further include one or more optional steps of adding one or more components to prepare the retinoid (e g., retinol) for use in various applications. For example, an antioxidant can be added to the isolated retinoid (e.g., retinol). Such a step can be particularly useful, for example, to make a cosmetic product, as the antioxidant can ameliorate or prevent oxidation of the cosmetic product formulation. Non-limiting examples of antioxidants include: butylated hydroxytoluene (BHT), camosic acid, tocobiol® SF ER (a mixture of tocopherol from sunflower oil and vegetable oil), tocobiol® XT (a mixture of tocopherol with green tea extract), tocobiol® SF (a mixture of tocopherol from sunflower oil), tocobiol® ER, tocobiol® (a mixture of tocopherol from vegetable oil or sunflower oil), alpha-tocopherol, tocopherol, D-alpha-tocopherol acetate, and propyl gallate.
Similarly, skilled practitioners will appreciate that methods described herein can further include adding various components to the isolated retinoid (e.g., retinol), or vice- versa, to produce various products. For example, the isolated retinoid (e.g., retinol) can be added to various other components to produce a cosmetic composition (e.g., essential oils, butters, oils). For example, a high oleic oil (e g., a high oleic sunflower oil) can be added to the isolated retinoid (e.g., retinol) to produce a cosmetic composition. Exemplary cosmetic compositions include skin creams, lotions, serums, sprays, moisturizers, and the like. As another example, the isolated retinoid (e.g., retinol) can be used to create a pharmaceutical composition, such as atopical composition or an injectable composition to treat various disorders. As yet another example, the isolated retinoid (e.g., retinol) can be formulated to be used as a dietary supplement, or added to various foodstuffs.
Methods of Isolating A Retinoid from a Composition
Provided herein are methods of isolating a retinoid from a composition including a retinoid and farnesol using a chromatography system. The methods can include, for example, providing a composition including a retinoid and famesol; feeding the composition into a chromatography system (e.g., a chromatography system comprising a hydrophobic
interaction chromatography resin (e.g., any of the hydrophobic interaction chromatography resins described herein)); and collecting the retinoid, thereby isolating the retinoid.
Because of the thermal instability of retinol, it is difficult to selectively separate retinol from famesol, a by-product from fermentation and an undesirable impurity for cosmetic applications. As briefly mentioned above, the structural similarities between retinol and famesol make their separation even more challenging. However, retinol can be selectively separated from farnesol using a chromatography system. Accordingly, provided herein are methods of isolating retinol from a composition including retinol and farnesol using a chromatography sy stem. The methods can include, for example, providing a composition including retinol and farnesol; feeding the composition into a chromatography system (e.g., a chromatography system comprising a hydrophobic interaction chromatography resin (e.g., any of the hydrophobic interaction chromatography resins described herein)); and collecting retinol, thereby isolating retinol.
In some instances, it may be useful to filter the composition comprising the retinoid (e.g., retinol) and farnesol prior to feeding the composition into a chromatography system. This filtration step can remove particulates in the liquid comprising the composition comprising the retinoid (e.g., retinol) and famesol that could clog or reduce the efficacy of the chromatography resin.
A chromatography system, as described herein, can include one or more chromatography resins and/or one or more chromatography columns. The chromatography system can include a hydrophobic interaction chromatography resin (e.g., any of the hydrophobic interaction chromatography resins described herein) or a reverse-phase chromatography resin (e.g., any of the reverse-phase chromatography resins). Exemplary chromatography resins include Purolite™ PCG600 (polystyrenic macroporous adsorbent non-functionahzed resm), Mitsubishi Diaion™ HP20SS (styrene-DVB porous adsorbent resin), Purolite™ PCG1200 (polystyrenic macroporous adsorbent non-functionahzed resin).
Non-limiting examples of hydrophobic interaction chromatography resins useful in the methods described herein can include those having a particle size of about 50 pm to about 900 pm (e.g., about 50 pm to about 600 pm, 50 pm to about 500 pm, 50 pm to about 200 pm, about 50 pm to about 150 pm, about 50 pm to about 100 pm, about 50 pm to about 80 pm, about 60 pm to about 600 pm, about 60 pm to about 500 pm, about 60 pm to about 200 pm, about 60 pm to about 180 pm, about 60 pm to about 120 pm, about 60 pm to about 100 pm, about 60 pm to about 80 pm, about 100 pm to about 600 pm, about 100 pm to about 500 pm,
about 100 pm to about 200 pm, about 100 pm to about 150 un, about 200 un to about 600 pun, about 200 pun to about 500 pun, or about 500 pun to about 600 pun).
Hydrophobic interaction chromatography resins can have a porosity of about 50 angstrom to about 500 angstrom (e.g., about 50 angstrom to about 200 angstrom, about 50 angstrom to about 100 angstrom, about 75 angstrom to about 250 angstrom about 75 angstrom to about 100 angstrom, about 100 angstrom to about 350 angstrom, about 100 angstrom to about 250 angstrom, about 100 angstrom to about 200 angstrom, or about 100 angstrom to about 150 angstrom).
In some instances, the chromatography system comprises a simulated moving bed chromatography. The simulated moving bed chromatography can be performed continuously over a period of at least 3 days (e.g., at least 7 days, at least 14 days, at least 20 days, at least 60 days, or at least 90 days).
It is well known in the art that a cycle of chromatography can vary depending on the specific biophysical properties of a target of interest (e.g., retinol), the chromatography resin(s), and mobile phases. For example, a hydrophobic chromatography column can include the steps of loading a hydrophobic interaction chromatography column with a fluid including a retinoid (e.g., retinol) and farnesol, washing the column to remove unwanted biological material (e.g., contaminating proteins and/or small proteins), eluting the retinoid (e.g., retinol) bound to the column, and re-equilibrating the column. It is also well-known in the art that any of the single steps in a chromatography cycle can include one or more mobile phases (e g., two or more mobile phases), and one or more of any of the single steps in a chromatography cycle can include a mobile phase gradient. In some instances, the chromatography system includes two or more (three or more, four or more, five or more, or six or more) cycles of chromatography.
Also provided herein are integrated, closed and continuous processes for isolating a retinoid (e.g., retinol). These processes include providing a composition including a retinoid (e.g., retinol) and famesol that is substantially free of fermentation broth, cells, cell debris, pollutants, and/or impurities. The process can include continuously feeding a liquid comprising the retinoid (e.g. ,retmol) and famesol into a simulated moving bed chromatography system with least one hydrophobic interaction chromatography resin (e g., Purolite™ PCG600 (polystyrenic macroporous adsorbent non-functionalized resin), Mitsubishi Diaion™ HP20SS (styrene-DVB porous adsorbent resin), Purolite™ PCG1200 (polystyrenic macroporous adsorbent non-functionalized resin), and wherein the process runs continuously from the liquid comprising the retinoid (e.g., retinol) and farnesol to an eluate
from the simulated moving bed chromatography that comprises isolated retinoid (e.g., retinol).
The processes described herein provide continuous and time-efficient production of a purified retinoid (e.g., purified retinol) from a liquid including a retinoid (e.g., retinol) and farnesol.
Compositions and Administration of Compositions
The compositions (e.g., cosmetic compositions, pharmaceutical compositions) including a retinoid produced by any of the methods and processes described herein can be in the form of a liquid, semi -liquid, or solid. The compositions can be formulated for oral administration, topical administration, or intravenous administration. In some instances, the composition is formulated as a sublingual drop, a gel capsule, or a spray. The compositions are administered in a manner compatible with the dosage formulation. A pharmaceutical composition can include a pharmaceutically acceptable carrier and/or an excipient. A pharmaceutical carrier can include any solvents, dispersion media, coatings, adjuvants, stabilizing agents, diluents, preservatives, antibactenal and antifungal agents, isotonic agents, adsorption delaying agents, and the like. In some instances, the composition is a lyophilized composition. Non-limiting examples of adjuvants include aluminum hydroxide, aluminum phosphate, saponins, water-in-oil emulsions, oil-in-water emulsions, and water-in-oil-in- water emulsion. Non-limiting examples of diluents include water, saline, dextrose, ethanol, glycerol, and the like. Non-limiting examples of isotonic agents include sodium chloride, dextrose, mannitol, sorbitol, and lactose.
The invention is further described in the following examples, which do not limit the scope of the invention described in the claims.
EXAMPLES
Example 1. Extraction of retinol from fermentation broth
This example demonstrates the effective recovery of retinol from the oil phase by solvent extraction. Skilled practitioners will appreciate that the order of steps described in this example can be modified in certain applications. Accordingly, the method described in the present example is not limiting to the methods of extractions described in the present disclosure.
300 L of whole cell broth and overlay containing 0.61 wt% retinol was subjected to solid-liquid centrifugation and a demulsification step followed by liquid-liquid centrifugation. The recovered light phase was the feed for an extraction step.
Solvent extraction was performed by mixing the crude oil from liquid-liquid centrifugation with a solvent extraction system to selectively extract retinol from the oil phase. Ethanol was used a solvent in these experiments. Screening of conditions for solvent extraction were conducted to determine the recovery yield at vary ing solvent/oil ratio and ethanol concentrations For each bench-scale experiment about 10 g of oil and ethanol/water mixture were combined in a 20 mL amber vial at the conditions described in Table 1. Samples were mixed for 30 minutes at 410 rotations per minute (rpm) at ambient temperature (~ 20 °C), then centrifuged at 3000 rpm for 15 minutes. The resulting oil and solvent layer were assayed for retinol quantification. The highest retinol recovery from oil layer was found with mass ratio 5: 1 solvent/oil and ethanol concentrations > 90 wt%.
A larger quantity of solvent extraction product was generated by combining 0.5kg crude oil and 90 wt% ethanol at 5:1 in an amber colored bottle and mixed using a stirring plate at 300-1000 rpm for at least 30 minutes at 20°C. The colored bottled was used to prevent retinol degradation by light exposure. Next, the mixture was transferred to a settling tank to decant for 1-3 hours. Then, the heavy phase, which contained the oil, was drained from the bottom of the vessel and the light phase, containing the ethanol/water and solvent mixture, was collected as a product. Results are shown in Table 2A. The process was scaled
to 1.5 kg of crude oil mixed with 90 wt% ethanol at 5: 1 in a tank with overhead stirrer (Table 2A).
Further retinol purification was achieved by solvent removal by evaporation at low temperature (less than or equal to 50°C) to avoid retinol degradation. Finally, the evaporation product was blended with sunflower oil to obtain the final desired formulation concentration (FIG. 1).
The fames ol/retinol in feed and famesol/retinol in product data in Table 2B demonstrate that it is not possible to separate these molecules using this method.
Additional commercial scale data is provided in Table 2B below. These results demonstrate scalability of the process. The same conditions were used in this experiment as for the bench-scale experiment described above: mass oil/mass solvent = 1:5 and solvent system was 90:10 ethanol/water.
Example 2. Retinol thermostability by normal evaporation
This example demonstrates the thermostability' of retinol in crude oil during evaporation.
The crude oil generated from solid-liquid centrifugation and liquid-liquid centrifugation of the fermentation broth and overlay was used as the starting material for the
following experiment. Microcentrifuge tubes containing crude oil were heated in a vacuum oven at 70°C for 1 - 48 minutes. After each time interval the tube was cooled in an ice bath and the solution was assayed by High-Performance liquid chromatography (HPLC) to determine the peak area percentage of all-trans retinol compared to 9-cis, 11-cis and 13 -cis retinol. Results are shown in Table 3. At the start of the experiment (t=0), 97.6% of all-trans retinol was present in the peak area. After 4 minutes at 70°C, the peak area percentage of all- trans retinol was 96%. After 8 minutes at 70°C, the peak area percentage of all-trans retinol was 95. 1% After 16 minutes at 70°C, the peak area percentage of all-trans retinol was 94.1%. After 24 minutes at 70°C, the peak area percentage of all-trans retinol was 93.1%; and after 48 minutes at 70°C, the peak area percentage of all-trans retinol was 90. 1%.
Example 3. Retinol thermostability by short-path evaporation
This example demonstrates thermostability of retinol during recovery by short path evaporation.
The crude oil generated after solid-liquid centrifugation and liquid-liquid centrifugation of fermentation broth was distilled using a 2” wiped film evaporation system (Pope Scientific Inc.). This evaporation technique is especially advantageous for heat sensitive molecules because of the shorter residence times. Distillate stream was collected and analyzed by HPLC to determine the peak area percentage of all-trans retinol compared to
9-cis, 11-cis, 13-cis and 9,13-cis retinol. The results are shown in Table 4. After 2.5 minutes at 200°C and 10 minutes at 200°C the evaporation product was found to contain 92.8% and 85% peak area all-trans retinol, respectively. After 30 minutes at 200°C, the evaporation product was found to contain 82.3% peak area all-trans retinol. After 2.5 minutes at 200°C and 20 minutes at 125°C the evaporation product was found to contain 98. 1% and 94.5% peak area all-trans retinol, respectively. At 50°C no significant degradation was observed under the time interval of the experiments (i. e. , between 0-240 minutes at 50 °C).
Example 4. Solvent removal by evaporation
Without wishing to be bound by theory, it was found that by operating evaporation under vacuum at lower temperatures, solvent could be removed without minimizing retinol
titer and avoiding all-trans isomer degradation. During these experiments, the temperature ranged from between 0 °C and 40 °C. The pressure ranged between 0. 1 torr and 100 torr.
Conditions
In this study, four different evaporation process configurations were tested - Rotorvap (under batch feeding), Rotorvap (under fed-batch feeding), 2-step evaporation without recirculation (under fed-batch feeding), and 2-step evaporation with recirculation (under fed- batch feeding). The experiments were carried out at bench scale (Rotorvap) and commercial scale (tank). See Table 5.
The study also allowed the testing of different “feeding modes”. According to fed- batch feeding, feed material was systematically added over the course of the run without removing any feed material. According to batch feeding, no feed material was added or removed over the course of the run. The feed mass was divided in small fractions for separate batch evaporations. The concentrated intermediates were then combined for a final evaporation.
Discussion
As shown in Table 5, there was minimal retinol degradation under all tested conditions. The retinol yield achieved at least 74%. A comparison between the two Rotorvap experiments demonstrated that the less contact the product had with heat, the greater retinol yield (98% retinol yield with Rotorvap with batch fractions as compared to 78% retinol yield with fed- batch feeding). The tested setups were exemplary and the results should not be limited to these setups. Other configurations are feasible and may yield similar results.
Table 5. Exemplary experimental results of evaporation at bench and commercial scale
Example 5. Determination of solvent extraction ratio for solvent extraction of polished crude oil
Trans-retinol is know n to be thermally labile. Thermal exposure can degrade transretinol into cis isomers. In an embodiment, the last step in the production of retinol was evaporation of retinol from polished crude oil in high-oleic sunflower oil (HOSUN). In another embodiment, a process of extracting the retinol into a solvent and then evaporating the solvent off was performed (FIG. 6). It was discovered that a solvent flash could be operated at a much lower temperature than overhead evaporation of retinol, thereby resulting in a much lower thermal degradation of retinol. Use of a wiped film evaporator (WFE) at low temperature could be used to remove solvents from retinol.
Materials and Methods
Ethanol was tested as the preferred solvent because it is volatile, readily dissolved retinol in concentrated form, exhibited a clean phase separation from HOSUN high oleic sunflower oil, and was globally available in non-genetically modified organism (GMO), kosher, and organic grade. Crude oil, which had been polished by centrifugation and then flashed to reduce water content, was tested as the crude oil feed at three solvent feed: oil extraction ratios : 5 : 1 , 3 : 1 , and 1 :1. Experiments were performed first in a glovebox to minimize the amount of moisture taken up in the solvent, and then outside of the glovebox to mimic conditions more suitable for scale-up to manufacturing. Gloveboxes maintain inert atmosphere (less than 1 ppm oxygen and moisture) either by removing the moisture and oxygen from the inert atmosphere of a glovebox or by constant purging of the glovebox with a positive pressure of inert gas. Table 6 outlines the relevant experimental conditions.
Table 6. Experimental Conditions
Each retinol extraction was performed in a 20 mL amber scintillation vial with the solvent (ethanol) and crude oil totaling 10 grams. After adding the solvent and crude oil to the vial, the mixture was stirred using a magnetic stir bar on a stir plate with a 20 mL scint vial adapter for 30 minutes at 410 rpm and ambient temperature (~ 20 °C). After mixing, the mixture was transferred to a centrifuge tube and centrifuged at 3000 rpm for 15 minutes. The four relevant streams for this process are shown in FIG. 7.
Following centrifugation, the oil feed and the solvent feed were both sampled and assayed for retinol quantification, isomer analysis and BHT quantification. A clean phase separation was observed following centrifugation. The solvent layer was removed using a serological pipette and a needle syringe was used to remove the oil layer. All measured data points from Tests 3-8 are provided in Table 7 and the calculated values of interest are shown in Table 8.
Results
The data collected from these experiments showed that, as the ethanol: feed ratio increased, so did the retinol and BHT yields. FIGs. 8A and 8B showed a positive correlation between ethanol: feed ratio and both retinol and BHT yields. These experiments also showed that yields were comparable between glovebox and out of glovebox handling. FIG. 9 showed a positive correlation between the ethanol extraction ratio and the BHT: retinol ratio, suggesting that a lower extraction ratio was more selective for retinol over BHT. Therefore, a lower extraction ratio was desirable to meet the BHT : retinol specification as defined in Table 8. Experiments performed within the glovebox had a slightly higher starting ratio (0.266) than experiments performed outside of the glovebox (0.259). However, this difference is believed to be negligible for scale-up manufacturing. Because there was little difference between glovebox and out of glovebox handling, it was determined that experiments could be performed at normal atmosphere.
An ethanol extraction ratio of 5 out of the ratios tested resulted in the best retinol yield. Lower extraction ratios tended to increase the retinol/BHT ratio in the extract, but this increased selectivity was not significant enough at this stage to pursue at the expense of retinol yield. A BHT: retinol mass ratio specification of 0.08-0.14 was desirable by reducing the BHT concentration in the fermentation broth and/or tuning the solvent water composition of the extraction solvent.
Experiments conducts outside of the glovebox did not have a discernible effect on retinol yields, and higher estimated retinol purities were observed with the experiments performed outside of the glovebox.
Example 6. Impact of water content and solvent/oil ratio in solvent extraction
To further investigate operating conditions, the impact of water content and solvent/water ratio on solvent extraction yield was studied using crude oils with different retinol concentrations.
Method
For each set of conditions, crude oil (A or B, containing 171 g/kg and 258g/kg of retinol, respectively) was mixed with ethanol/water solution (80%, 85%, 90% and 95% ethanol) at a defined ratio solvent oil (1 :1, 5: 1 and 9: 1) to reach a total mass of 10g. The mixture was centrifuged at 5000 rpm for 30 minutes. The final solvent and oil layers were recovered and analyzed for retinol titer to calculate process yield.
Discussion
The results shown in Table 9 demonstrate that higher ethanol concentration in the solvent system is beneficial to the extraction yield. The trend also indicates that increasing the ratio of solvent system to feed oil improves yield, though the extent of that improvement may be limited by costs of solvent consumption by increasing solvent: oil ratio and ethanol%. Results also indicate the impact of feed titer on yield is more significant for conditions in the lower range of ethanol% and solvent: oil ratio tested.
Table 9. Extraction yield of retinol [%] from crude oil for a range of feed titer (A: 171g/kg retinol, B: 258 g/kg), ethanol/water% and solvent:oil conditions
Example 7. Testing different sources of ethanol
Ethanol sources may contain additives (e.g., denaturants) that make ethanol unsafe for consumption while still being acceptable for other uses. Undenatured ethanol is an example of an ethanol that is free of additives.
Method
Crude oil was mixed with 90: 10 v/v ethanol/water at a ratio of 1 :5 wt oil/solvent.
Table 10 provides the list of ethanol solutions that were tested. The total volume of each
ethanol solution was approximately 250 rnL. First, each ethanol solution was mixed for at least 30 minutes. Next, the ethanol solution was poured into a separation funnel to decant for more than 2 hours. Lastly, the oil layer and the solvent layer were separated and analyzed for retinol concentration.
Discussion
As shown by the retinol yield obtained in Table 10, denaturants are effective for use in retinol extraction from crude oil. All of the tested ethanol solutions - which varied depending on the mixture of denaturants - had a retinol yield of at least 70%. The highest retinol yield was obtained in an ethanol solution comprising >90% ethanol, between 3-5% methanol, between 1-5% ethyl acetate and between 1-5% 4-methylpentan-2-one.
Table 10. Extraction yield of retinol from crude oil using different sources of ethanol for a 90:10 vol ethanol/water system
Example 8. Impurity removal by chromatography
This example demonstrates the separation of retinol from famesol, a C15 sesquiterpene alcohol (C15H26O). Famesol can be a by-product from fermentation and an undesirable impurity for cosmetic applications. Retinol and farnesol are structurally similar, which makes their separation challenging. Moreover, the thermal instability of retinol limits the possibility of separation of retinol and farnesol by evaporation, as illustrated in Example 2 and Example 3. Chromatography using hydrophobic adsorbents was found to be an efficient and scalable process for retinol/famesol resolution.
Screening of hydrophobic resins was conducted to evaluate retinol/famesol separation and guided the choice of process conditions. A 0.5 mL reference solution containing 1 wt% retinol, 1 wt% farnesol and 0.01 wt% butylated hydroxy toluene (BHT) in 90/10 vol% ethanol/water was injected into each column (ID 1.6cm) packed with 15 g of resin and preconditioned at 90/10 vol% ethanol/water. The columns were then washed with 40/60 vol% ethanol/water over 3 bed volumes (BV), eluted with the gradient 40-100 vol% ethanol over 20 BV, and flushed with 100% ethanol over 5 BV. The wash and elution flowrates were set at 2 BV/hour. Retinol and farnesol peaks were identified by absorbance at 325 and 200 nm, respectively. Resulting chromatograms are shown in FIGs. 4A-C. The elution volumes at mid peak are indicated in Table 11 for three exemplary resins, Diaion HP20SS, Purolite™ PCG600, and Purolite™ PCG950, that resulted in clear retinol/famesol resolution. Hydrophobic adsorbents Diaion™ HP20, Sepabeads™ SP70, Sepabeads™ SP700 and Sepabeads™ SP207 are examples of resins that did not results in efficient retinol/famesol resolution in the abovementioned conditions.
Table 11. Elution of retinol and farnesol from chromatography resins
Example 9. Retinol purification by chromatography
Ethanol solvent extract solutions containing 2.6 - 3.1 wt% retinol and 1.4 - 2.4 wt% famesol/retinol ratio were produced as described in Example 1. The solvent extraction was then followed by a filtration step, a chromatography step for product purification, solvent evaporation and blending steps (FIG. 5).
The solvent layer of the solvent extraction w as filtered using a 0.45 microns filter media to remove any remaining cell debris that could impact chromatography performance. The permeate was pumped into a column (ID 1.6 cm) packed with Diaion HP20SS (Mitsubishi Chemical) pre-conditioned at 90/10 vol% ethanol/water. The column was first washed with 5 BV of 70/30 vol% ethanol/water and then eluted with 5 BV of 85/15 vol%
ethanol/water and 5 BV of 96/4 vol% ethanol/water. Finally, the column was flushed with 100% ethanol over 5 BV. The elution concentration profiles of both retinol and famesol were determined by HPLC analysis of chromatography fractions. The product cut, i.e., purified retinol, was selected after elution of famesol. Two columns with different bed heights were evaluated over a range of resin loadings (0.5 - 2.5 wt% retinol fed into column/resin). Column details and performance results are shown in Table 12. Surprisingly, given the structural similarity between farnesol and retinol discussed above, little to no farnesol was detected in the product streams, with famesol/retinol ratios < 0.08 wt%. Even though no particular trend in yield was observed by the increase in loading, the process yielded > 70% of retinol. While not wishing to be bound by theory, we theorize that by selecting the product cut based on the concentration profile during elution steps rather than a fixed elution step generated the variability in yield. Furthermore, the results show that separation of retinol from farnesol was efficient even at relatively higher loadings (e.g., 2.0 wt% retinol fed/resin and 2.3wt% retinol fed/resin).
Table 12. Retinol yield and purity through chromatography process
The product stream was then evaporated at low temperature and pressures to remove ethanol: 20 - 40°C and 0. 1 - 70 torr. After evaporation, the retinol product was blended with high oleic organic sunflower (HOSUN) oil to generate the final retinol product.
The results in Table 13 below demonstrate the scalability of the process.
Example 10. Chromatography Reproducibility
In this study, a fixed protocol was repeated over 22 consecutive cycles to verify repeatability.
Method
The feed was a solvent extraction product containing 2.5wt% retinol and 1 .6 wt% Famesol/Retinol ratio. The packed chromatography column (bed height 14 cm, bed volume (BV) 28 mL) contained 15 g of Diaion HP20SS resin. The column was equilibrated with 90% ethanol before loading feed solution at 2% retinol/resin. Then the column was washed with 5 BV of 70/30 vol% ethanol/water and the target molecule eluted with 5 BV of 85/15 vol% ethanol/water. Then 5 BV of 95/5 vol% ethanol/water were applied to strip more hydrophobic components. The column was cleaned between each cycle with 5 BVs of isopropyl alcohol.
Results
As shown in FIG. 10, the retinol yield dropped between the first 6-7 cycles, which is a common effect for this type of resin. However, the yield became constant and stayed consistent over 22 consecutive cycles without the need for regeneration. The product purity was consistently high, with low amounts of farnesol in the product (below 0.05 wt% Famesol/Retinol). See also FIG. 10.
Varying Wash and Elution conditions
The process may vary in wash, elution and strip conditions for different yield, purity and solvent consumption.
Method
The feed was a solvent extraction product containing 2 wt% retinol and 1.9 wt% Famesol/Retmol ratio. The packed chromatography column (bed height 24 cm, bed volume (BV) 48 mL) contained 23 g of Diaion HP20SS resin. The column was equilibrated with 90% ethanol before loading feed solution at 2% retinol/resin. Wash, elution and strip steps conditions are described in Table 14. The column was cleaned after each cycle with 5 BVs of isopropyl alcohol.
Table 14: Exemplary experimental results for farnesol removal by varying wash and elution conditions
Discussion
As shown by the data in Table 14, the vary ing wash and elution conditions greatly enhanced the retinol yield. Increasing the wash strength (higher ethanol%) resulted in better purity, but led to a lower retinol yield.
The most relevant steps in this process were the wash and elution steps. Farnesol is eluted during the wash step and retinol is eluted during the elution step. Little retinol or farnesol are seen in the strip step. The strip step is useful to strips out more hydrophobic components. Though it seemed like removing the strip step resulted in lower yield (comparison of Runs 3 and 6), the difference in retinol yield was attributed to the use of the
resin (HP20SS), i.e. running consecutive cycles in this column, and lower total mass balance recovered rather than retinol lost in the strip step.
Antioxidant
Chromatography process can partially or totally separate the antioxidant (e.g. BHT, Tocobiol®, or Tocobiol® SF ER) from retinol. To avoid oxidative degradation, an antioxidant (e.g., BHT, Tocobiol®, or Tocobiol® SF ER, or any of the antioxidants described herein) can be added to the chromatography product.
OTHER EMBODIMENTS
It is to be understood that while the invention has been described in conjunction with the detailed description thereof, the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are within the scope of the following claims.
Claims
1. A method of isolating a retinoid, the method comprising: providing a fermentation broth comprising the retinoid and an overlay; performing a liquid-solid and a liquid-liquid separation on the fermentation broth to produce a crude oil and a waste heavy phase; mixing the crude oil with a solvent extraction system to extract the retinoid from the crude oil; and stripping the solvent extraction system from the extracted retinoid to thereby isolate the retinoid.
2. The method of claim 1, wherein the solvent extraction system comprises ethanol, isopropyl alcohol (IP A), acetone, or propanediol, or a combination thereof.
3. The method of claim 2, wherein the solvent extraction system comprises about 70 wt% to about 99.95 wt% ethanol.
4. The method of claim 1, wherein the solvent extraction system comprises acetic acid, acetonitrile, methanol, n-propanol, methyl acetate, ethyl acetate, n-hexane, cyclohexane, or n- heptane.
5. The method of claim 2, wherein the solvent extraction system comprises ethanol, wherein the ethanol is free of additives.
6. The method of claim 5, wherein the ethanol free of additives is a denatured ethanol.
7. The method of claim 1, wherein the solvent extraction system comprises ethanol and isopropyl alcohol.
8 The method of claim 1, wherein the solvent extraction system comprises ethanol and n-heptane.
9. The method of claim 1, wherein the solvent extraction system comprises ethanol, methanol, ethyl acetate, and 4-methylpentan-2-one.
10. The method of claim 1, wherein the solvent extraction system comprises methylene chloride, ethyl ether, chloroform, or carbon tetrachloride.
11. The method of claim 1, wherein the water content in the solvent extraction system is between about 0% to about 60%.
12. The method of any one of claims 1-11, wherein the mass ratio of the solvent extraction system to crude oil ranges from about 10: 1 to about 100:1.
13. The method of any one of claims 1-11, wherein the mass ratio of the solvent extraction system to crude oil ranges from about 1 : 1 to about 5:1.
14. The method of claim 1, wherein the overlay comprises a mineral oil and/or a vegetable oil.
15. The method of claim 14, wherein the overlay comprises mineral oil, and the mineral oil is Durasyn® 164 polyalphaolefin or Drakeol® 10.
16. The method of claim 14, wherein the overlay comprises vegetable oil, and the vegetable oil is butter, bisabolol oil, canola oil, castor oil, cocoa butter, coconut oil, cod liver oil, com oil, cottonseed oil, grape seed oil, jojoba oil, kapok seed oil, linseed oil, olive oil, palm kernel oil, palm oil, patchouli oil, peanut oil, poppyseed oil, rapeseed oil, rice bran oil, safflower oil, soybean oil, sunflower oil, tung oil, walnut oil, or wheat germ oil, or a mixture thereof.
17. The method of claim 1, wherein the liquid-liquid separation comprises centrifugation, filtration with a functionalized membrane, tangential flow filtration, and/or sedimentation.
18. The method of claim 1, wherein the stripping the solvent extraction system comprises decanting for about 30 minutes to about 24 hours.
19. The method of claim 1, wherein stripping the solvent extraction system comprises a solvent evaporation or fractional distillation.
20. The method of claim 19, wherein the solvent evaporation is performed in a single step.
21. The method of claim 19, wherein the solvent evaporation is performed in multiple steps.
22. The method of claim 19, wherein the solvent evaporation comprises a rising-film evaporator, a falling-film evaporator, a wiped film evaporation, an agitated thin film, or a plate.
23. The method of claim 21, wherein the solvent evaporation is performed in two-steps.
24. The method of claim 23, wherein the solvent evaporation is performed in two-steps with recirculation or without recirculation.
25. The method of claim 1, wherein stripping the solvent extraction system comprises evaporating the solvent at a temperature of less than about 50 °C.
26. The method of claim 1, wherein stripping the solvent extraction system comprises evaporating solvent at a temperature of about 50 °C to about 200 °C.
27. The method of claim 1, wherein the method further comprises feeding the isolated retinoid into a chromatography system comprising a hydrophobic interaction chromatography resin or a reverse-phase chromatography resin.
28. The method of claim 27, wherein the hydrophobic interaction chromatography resin is a hydrophobic interaction chromatography resin with a particle size of about 63 pm to about 150 pm.
29. The method of claim 28, wherein the method further comprises filtering the isolated retinoid prior to feeding the isolated retinoid into the chromatography system.
30. The method of claim 29, wherein the method further comprises evaporating solvent at a temperature less than 50 °C.
31. The method of claim 27 or 29, wherein the method further comprises adding a high oleic oil thereby producing a cosmetic composition.
32. The method of claim 31, wherein the high oleic oil is a high oleic organic sunflower oil.
33. The method of claim 1, wherein the retinoid is retinol.
34. A method of isolating a retinoid from a composition comprising the retinoid and famesol, the method comprising: providing a composition comprising the retinoid and famesol: feeding the composition into a chromatography system; and collecting the retinoid, thereby isolating the retinoid.
35. The method of claim 34, wherein the chromatography system comprises a hydrophobic interaction chromatography resm or a reverse-phase chromatography resm.
36. The method of claim 35, wherein the hydrophobic interaction chromatography resin is a hydrophobic interaction chromatography resin with a particle size of about 63 pm to about 150 pm.
37. The method of claim 34, wherein the chromatography resin is Purolite™ PCG600, Mitsubishi Diaion™ HP20SS, Purolite™ PCG1200.
38. The method of claim 34, wherein the method further comprises filtering the isolated retinoid prior to feeding the composition into the chromatography system.
39. The method of claim 34, wherein the method further comprises evaporating solvent at a temperature less than 50 °C.
40. The method of claim 39, wherein the method further comprises adding a high oleic oil thereby produce a cosmetic composition.
41. The method of claim 40, wherein the high oleic oil is a high oleic organic sunflower oil.
42. A composition comprising the retinoid produced by the method of any one of claims 1-41.
43. The composition of claim 42, wherein the composition is a liquid or a semi-liquid.
44. The composition of claim 42, wherein the composition is formulated for oral administration, topical administration, or intravenous administration.
45. The composition of claim 42, wherein the composition is formulated as a sublingual drop, a gel capsule, or a spray.
46. A cosmetic composition comprising the retinoid produced by the method of any one of claims 1-41.
47. A pharmaceutical composition comprising the retinoid produced by the method of any one of claims 1-32 and a pharmaceutically acceptable carrier and/or excipient.
48. The pharmaceutical composition of claim 47, wherein the pharmaceutically acceptable carrier and/or excipient is an adjuvant.
49. A composition comprising a retinoid, wherein the retinoid is produced by a method comprising: a) culturing a population of host cells that are genetically modified to express one or more enzymes of a retinoid biosynthetic pathway in a culture medium and under conditions suitable for the population of host cells to produce the retinoid, thereby producing a fermentation composition; and b) recovering the retinoid from the fermentation composition, wherein the retinoid is present in the composition with a purity of between 40% w/w and 99.9% w/w.
50. A method of isolating a retinoid, comprising: a) culturing a population of host cells that are genetically modified to express one or more enzymes of a retinoid biosynthetic pathway in a culture medium and under conditions suitable for the population of host cells to produce the retinoid, thereby producing a fermentation composition; and b) recovering the retinoid from the fermentation composition, wherein the retinoid is present in the composition with a purity of between 40% w/w and 99.9% w/w.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202263374274P | 2022-09-01 | 2022-09-01 | |
US63/374,274 | 2022-09-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2024050080A2 true WO2024050080A2 (en) | 2024-03-07 |
WO2024050080A3 WO2024050080A3 (en) | 2024-04-18 |
Family
ID=88192119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2023/031838 WO2024050080A2 (en) | 2022-09-01 | 2023-09-01 | Methods of biomanufacturing and purifying retinoids |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024050080A2 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9644217B2 (en) * | 2011-07-29 | 2017-05-09 | Industry-Academic Cooperation Foundation Gyeongsang National University | Method for producing retinoid from microorganism |
EP4237574A1 (en) * | 2020-10-30 | 2023-09-06 | DSM IP Assets B.V. | In situ two-phase extraction system |
-
2023
- 2023-09-01 WO PCT/US2023/031838 patent/WO2024050080A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2024050080A3 (en) | 2024-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110642679B (en) | Method for preparing cannabidiol and coproducing cannabis full spectrum oil | |
EP2040810B1 (en) | Improved chromatography process for recovering a substance or a group of substances from a mixture | |
EP1818388B1 (en) | Process for production of highly enriched fractions of natural compounds from Palm Oil with supercritical and near critical fluids | |
Chuang et al. | Concentration of minor components in crude palm oil | |
CN111487356B (en) | Method for separating coenzyme Q10 by using supercritical fluid chromatography system | |
JP2960918B2 (en) | Method and apparatus for purifying lower alcohol esters of high purity highly unsaturated fatty acids | |
KR102289886B1 (en) | Chromatographic method for producing polyunsaturated fatty acids | |
EP3029021A1 (en) | Method for separating fat-soluble material by simulated moving bed chromatography, and device for same | |
CA2624376C (en) | A process and an apparatus for producing episesamin-rich compositions | |
CN107778277B (en) | Process for the recovery of squalene, vitamin E and/or sterols | |
KR20160096110A (en) | Method for chromatographic purification of a fatty acid | |
FR2955785A1 (en) | LIQUID / LIQUID EXTRACTION | |
KR20110119071A (en) | A preparative method for isolation of fucoxanthin from seaweeds by centrifugal partition chromatography | |
WO2002042287A1 (en) | Method for chromatographic preparation of tocotrienol | |
CN103203122A (en) | Method for separating and purifying high-purity natural substances from animals and plants by using liquid chromatography column | |
Fábryová et al. | High-performance countercurrent chromatography for lutein production from a chlorophyll-deficient strain of the microalgae Parachlorella kessleri HY1 | |
Jangle et al. | Phosphatidylcholine and its purification from raw de-oiled soya lecithin | |
JPH0873396A (en) | Lipid having high natural menaquinone-7 content | |
EP3305754A1 (en) | Process for producing highly unsaturated fatty acid of high purity in high yield | |
WO2024050080A2 (en) | Methods of biomanufacturing and purifying retinoids | |
WO2012169443A1 (en) | Method for manufacturing refined vegetable squalene and refined vegetable squalene | |
KR102289237B1 (en) | Purification of fatty acids by a chromatographic method | |
CN113260709A (en) | Method for extracting pigments from microalgae | |
US20230034720A1 (en) | Systems and methods for cannabis cbd extraction | |
CN113754526A (en) | High-purity coenzyme Q10 purification process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23776779 Country of ref document: EP Kind code of ref document: A2 |